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Abstract
Tumour motion presents a significant limitation for effective radiotherapy of lung cancer,
and more specifically for helical tomotherapy. The simultaneous and continuous movements
of tomotherapy subsystems (gantry, couch, and binary multi-leaf collimator) can lead to
inaccurate dose delivery, when combined with tumour motion. In this thesis, we have
investigated the impact of tumour motion and strategies to reduce the resulting dose
discrepancies for helical tomotherapy, through computer simulations and film measurements
performed in a dynamic body phantom.

Three distinctively different types of dose

discrepancies have been isolated: dose rounding, dose rippling, and the intensity-modulated
radiation therapy (IMRT) asynchronization effect. Each effect was shown to be affected by
different combinations of tumour motion and treatment parameters. In clinical practice using
a conventional fractionation scheme, the dose rounding effect remains the major concern,
which can be compensated by assigning a larger treatment margin around the tumour volume.
For hypofractionation schemes, the IMRT asynchronization effect can become an additional
concern by introducing dose discrepancies inside the target volume, necessitating the use of a
motion management technique.
Two new motion management techniques have thus been developed for helical tomotherapy:
loose helical tomotherapy with breath-holding and multi-pass respiratory gating.

Both

methods require the treatment couch to be reset to its starting position to repeat the entire
helical treatment, until nearly all planned dose is delivered. For sinusoidal target motion,
employing multi-pass respiratory gating was shown to reduce the dose deviation inside the
target volume from 14% to 2% for a single fraction, using 4 gated passes. For non-sinusoidal
tumour motion causing a dose deviation of 6% within the tumour volume, the required
number of passes to keep the dose deviation below 1% was approximately 4 passes for 30
fractions and 5 passes for 3 fractions, demonstrating the feasibility of the multi-pass
respiratory gating approach. Clinical implementation of the multi-pass respiratory gating
technique would require a number of electronic control and communication modifications to
the existing tomotherapy machine, which would lead to significant improvements in the dose
distributions delivered for lung tomotherapy treatments – especially for patients exhibiting
large tumour motion who are treated with hypofractionation schemes.
iii
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Chapter 1
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Introduction

This chapter provides a background overview of the research work presented in this
thesis dissertation, as well as the research objectives, hypothesis, scope, and the roadmap
of this thesis work.

1.1 General Overview
In 2009, there were an estimated 171,000 new cancer cases and 75,300 cancer-related
deaths in Canada. Lung cancer accounted for 14% of all cancer incidences, but caused
27% of all cancer deaths, making it the leading cause of cancer deaths in Canada. The 5year overall survival rate for lung cancer has been historically very low at 15%,
compared to the average value of 62% for all cancer sites [1]. There is a clear need to
improve the treatment of this disease.
Three different approaches routinely used for treating cancer are surgery, radiotherapy,
and chemotherapy. For non-small cell lung cancer (NSCLC), these treatment methods
may be used individually, or in combinations.

Surgery has shown to yield highly

successful clinical outcomes, with 5-year overall survival rates in the range of 50-70%
[2,3]. However, surgery is suitable for only one-third of all patients, who are mostly in
the early stages of the disease. The inoperable NSCLC patients may be treated with
radiotherapy alone, or in combination with chemotherapy. For medically inoperable
NSCLC, early stage patients account for 10-15%, while locally advanced cases make up
for 30-40% of the patient population [4].1 When radiotherapy with conventional dose
prescription is used alone, the 5-year overall survival rates are in the range of 6-32% for
the early stage cases, while generally not exceeding 5% for the locally advanced cases
[5,6].
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Although different treatment schemes may be employed to improve the

The remaining 12-27% of NSCLC patients account for more advanced cases.
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effectiveness of traditional radiotherapy, the resulting clinical outcomes still remain far
inferior to those achievable with surgery [2-5].
Recently, stereotactic body radiotherapy (SBRT) has emerged as a promising technique
to improve clinical outcomes for early-stage NSCLC, achieving results comparable to
surgery through intensified dose regimens [7-14]. There have been a number of clinical
studies in North America, Europe, and Asia, investigating the effectiveness of stereotactic
body radiotherapy (SBRT), employing a very small number of dose fractions
(hypofractionation) for treating NSCLC.

From the currently on-going clinical trial

(RTOG 2306), 2-year and 3-year overall survival rates of 54.7% and 42.7% have been
reported, respectively [9,10]. In a different study, 5-year overall survival rates as high as
72% and 83% have been observed [11], while 3-year overall survival rates of 47-60%
were reported in several multi-institutional studies [12-14].

However, there are

remaining concerns for normal tissue complications in the areas of skin, chest wall and
rib, due to the high dose given during each fraction [15]. Thus, more long-term data will
be required to determine whether SBRT can be adopted as the new standard radiotherapy
practice for early stage NSCLC.
Local recurrence is the major reason for high failure rates of lung cancer radiotherapy [7].
Local relapse rates of 6 to 70%, with a median of 40%, have been reported from various
studies [16,17].

The major contributing factor for high local recurrences is the

insufficient dose given to the tumour volume, limited by the dose tolerance of
surrounding organs at risk (OAR), such as normal lungs, heart, and spinal cord.
Radiosensitivity of surrounding lung tissues places a limit on the maximum dose
deliverable to the tumour volume, so that radiation-induced complications, such as
radiation pneumonitis and radiation fibrosis, can be avoided [18]. The effort to spare
lung tissues, however, comes at the expense of local tumour control. Local tumour
control has been shown to improve with dose escalation [2,4,5,12]. The presence of
tumour motion driven by patient breathing [19-22] further limits the maximum dose
deliverable to the tumour volume, as an additional margin is generally assigned around
the tumour volume to encompass the entire range of tumour motion. This significantly
increases the total irradiated volume of normal lung tissues [20].

In addition, the
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presence of tumour motion during dose delivery can generate unwanted dose
discrepancies inside the tumour volume [20].
Thus, for lung radiotherapy, the use of a highly conformal dose delivery technique
becomes essential for improving normal tissue sparing, while simultaneously enabling
dose escalation. In the presence of tumour motion, it is crucial to minimize the required
margin size and the magnitude of motion-induced dose discrepancies, by employing an
effective motion-management method for the chosen dose delivery technique. In this
dissertation, helical tomotherapy was selected as the dose delivery technique for lung
cancer, due to its highly conformal dose delivery capability. Motion management for
helical tomotherapy becomes the focal point of this thesis, as motion management is
currently not available clinically for helical tomotherapy.

In this work, we have

identified and systematically categorized the different types of motion-induced dose
discrepancies for helical tomotherapy, while investigating their characteristics in relation
to different treatment and respiratory parameters.

Feasibility of breath-holding and

respiratory gating techniques for helical tomotherapy was then investigated, in terms of
their effectiveness for reducing the magnitude of the different motion-induced dose
discrepancies.

1.2 Radiation Therapy Techniques
The goal of radiation therapy is to concentrate the dose of radiation to the tumour volume,
while minimizing the dose to surrounding normal structures. During the course of a
radiation treatment, the prescription dose is usually divided up and delivered in multiple
fractions, over a period of weeks, rather than completed in its entirety in a single fraction.
The purpose of dose fractionation is to preserve the normal tissues, while allowing cell
cycle redistribution and reoxygenation of the tumour cells for more effective tumour cell
killings [23].

For conventional lung radiotherapy, a prescription dose of 60 Gy is

typically delivered over 30 fractions with 2 Gy given per fraction.
For radiotherapy, a linear accelerator (Figure 1.1) is conventionally used to deliver
radiation dose distribution conformal to the target volume. A patient is placed on the
treatment couch, while a mega-voltage x-ray beam is generated and emitted from the
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gantry head. The gantry can be rotated to treat the tumour volume from various angles.
In Figure 1.2, the radiation is shown to be delivered to the lung tumour volume, outlined
by the yellow contour, using four treatment beams from different gantry angles. In the
resulting dose distribution shown in percentage of the prescription dose, the tumour
volume is being covered by the high dose region shown in red (95%), while the other
normal structures such as lungs, heart, and spinal cord are located in the low dose regions,
depicted in cyan (40%) and blue (20%). Various radiation delivery techniques have been
proposed and used over the years, in an effort to improve dose conformity and normal
tissue sparing. The different techniques will be described in the order of complexity in
following sections.

Figure 1.1: Photograph of a Varian Clinac iX linear accelerator (Varian Medical
Systems, Palo Alto, CA) at London Regional Cancer Program.
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Figure 1.2: Dose distribution of a 4-beam plan for a lung lesion (yellow). The red
colour represents high dose region receiving more than 95% of the prescription dose,
while the low dose regions are depicted with cyan (40%) and blue (20%). The ‘red’
beam profiles depict the unique fluence patterns (i.e. intensity modulation) for each
of the treatment beams.

1.2.1

Three-Dimensional Conformal Radiation Therapy (3D-CRT)

Three-dimensional conformal radiation therapy (3D-CRT) is performed by shaping each
treatment beam according to the projected target shape at a given gantry angle [24]. The
beam aperture can be modified with shielding blocks, or by utilizing a multi-leaf
collimator (MLC) [25,26]. An example of a MLC system is shown in Figure 1.3, which
consists of 120 collimator leaves for shaping a radiation field and/or generating intensity
modulation within the field.
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Figure 1.3: Varian 120 leaf Millennium multi-leaf collimator (MLC) (Courtesy of
Varian Medical Systems, Palo Alto, CA, Image from www.varian.com).

1.2.2

Fixed Gantry Intensity Modulated Radiation Therapy (IMRT)

Intensity modulated radiation therapy (IMRT) is an advanced form of 3D-CRT that
utilizes conformal radiation fields with non-uniform fluence, with an intent to deliver
uniform dose to the tumour volume [27]. The built-in MLC system of the conventional
linear accelerator allows for an IMRT delivery to be carried out either in a “step-andshoot” or “sliding window” mode [28]. In the “step-and-shoot” approach, a sequence of
static segments shaped by the MLC leaves is delivered at a fixed gantry angle, while in
the “sliding window” mode, also known as the “dynamic MLC” approach, the MLC
leaves move continuously during irradiation at a fixed gantry angle.
The dose conformity and normal tissue sparing can be further improved by increasing the
number of fixed gantry angles, from which radiation is delivered. In Figure 1.3, a
conformal dose distribution is generated by assigning each of the four treatment beams
with unique and non-uniform fluence patterns represented by the ‘red’ beam profiles. An
additional degree of freedom may be introduced by using the couch angle for noncoplanar treatments [29].
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1.2.3

Rotation Therapy

The benefits of using multiple beams to improve dose conformity can be fully exploited
by employing continuous gantry rotation during radiation delivery. The treatment may
consist of a single or multiple arcs, where each individual arc may cover up to a full 3600
rotation [30-36].

Traditional rotation therapy used a fixed beam aperture shaped

according to the target volume for the entire dose delivery [30]. In a specialized case
with a fixed beam aperture, both gantry and couch rotations may occur simultaneously, as
in dynamic stereotactic radiosurgery (DSR) [37,38].
For conformal arc therapy, rotational dose delivery is made with a dynamic MLC to
adapt the beam aperture according to the projected target shape at each gantry angle [31].
Intensity modulated arc therapy (IMAT) utilizes a dynamic MLC to deliver a single level
of fluence to the target volume during each individual arc [32-34]. Thus, multiple arcs
are normally required to generate more complex fluence patterns for IMAT. Volumetric
modulated arc therapy (VMAT) is capable of achieving the planned dose distribution in a
single rotation, by introducing additional degrees of freedom of varying the gantry
rotation speed and dose rate [35,36].

The currently available commercial systems

employing the VMAT technique include Varian RapidArc (Varian Medical Systems,
Palo Alto, CA), and Philips SmartArc (Philips Healthcare, Andover, MA).

Varian

Medical Systems has recently upgraded their RapidArc system to allow for the delivery
of multiple arcs to generate even more sophisticated fluence patterns for radiation therapy.

1.2.4

Tomotherapy

In contrast to the use of a cone beam of radiation that covers the entire target volume, the
target volume may also be treated in slices by utilizing a fan beam of radiation. Such
delivery techniques can further improve the capability of producing more sophisticated
in-plane fluence patterns, but at the expense of prolonged treatment time.

1.2.4.1

Serial Tomotherapy

For serial tomotherapy, each slice within the target volume is treated with a full or partial
gantry rotation. After completing the dose delivery to each target slice, the treatment
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couch is indexed to the next target slice position for irradiation [39]. The fluence within
the fan beam is modulated by two rows of 64 binary MLC (b-MLC) leaves that either
move in or out of the fan beam field. Intensity modulation is achieved by varying the
duration of each leaf opening as a function of beam projection. However, the treatment
couch indexing between target slices introduces couch positional uncertainty, which can
lead to unwanted “hot or cold” dose spots at the junctions of slices. This problem can be
resolved by employing a continuous couch motion that occurs simultaneously with the
gantry rotation, as in the case for helical tomotherapy.

1.2.4.2

Helical Tomotherapy

Helical tomotherapy combines continuous gantry rotation and linear couch motion to
deliver a 6 MV x-ray fan beam to the target volume in a helical manner [40-42]. A HiArt II helical tomotherapy unit (TomoTherapy Inc., Madison, WI) is currently being used
clinically at London Regional Cancer Program (Figure 1.4 a). The fan beam has a
projected width (X) of 40 cm at the isocenter (SAD = 85 cm), which is further divided
into 64 beamlets by a single row of binary multi-leaf collimator (b-MLC) leaves (Figure
1.4 b). There are three different available fan beam thickness (b) of 1.05 cm, 2.5 cm, and
5.0 cm projected at the isocenter along the longitudinal direction (Y).
Other helical tomotherapy parameters include pitch factor, and gantry rotation period.
Pitch factor (p) is defined as the longitudinal (Y) distance advanced by the treatment
couch per gantry rotation, in units of fan beam thickness (b). Gantry rotation period (Tg)
is the time required to complete one full 3600 rotation. Gantry rotation periods of less
than 20 s are typically used clinically for lung tomotherapy.

For dose calculation

purposes, each gantry rotation is virtually divided into 51 equally-spaced beam
projections (each spanning ~70), during which the individual b-MLC leaves either travel
into and out of the fan beam field. Intensity modulation is achieved by varying the
durations of individual leaf openings for each beam projection.
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Figure 1.4: Photographs of a) Hi-Art II helical tomotherapy machine
(TomoTherapy, Inc., Madison, WI) at London Regional Cancer Program, and b)
binary multi-leaf collimator (b-MLC).
The helical tomotherapy unit was the first radiotherapy machine to incorporate an on-line
CT imaging capability for patient set-up verification at the start of each treatment fraction.
The mega-voltage CT (MVCT) images of a patient acquired with the downshifted energy
of 3.5 MV are compared to the planning kilo-voltage (kV) CT images to ensure that the
patient is appropriately positioned [43,44].

1.3 Image Guidance Techniques
Historically, for radiotherapy, the patient position used during the treatment planning
process was replicated mainly with the help of skin tattoos at the start of each treatment
fraction [45,46]. However, the internal anatomy can change in relation to the patient
surface, between the time of CT imaging for treatment planning and the start of a
treatment fraction [47,48]. Thus, relying solely on the skin tattoos for patient set-up is
insufficient, due to the tumour position uncertainty arising from the interfraction variation
of patient anatomy. Although the dosimetric errors caused by the interfraction variation
of tumour position may average out over multiple fractions with the use of a proper
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margin [49-51], the use of image guidance to directly verify tumour position at the start
of each treatment fraction becomes essential in accurately delivering the planned dose
distribution to the tumour volume. This will allow for a possible margin reduction to
lower radiation toxicity, as well as dose escalation for an increased local tumour control
[52,53].

In some instances, it also becomes necessary to track the tumour position in

real-time to account for the intrafraction variation of the tumour position. In this section,
the different methods to monitor the interfraction and intrafraction variation of tumour
position will be described.

1.3.1

Two-Dimensional (2D) Mega-Voltage (MV) Imaging

Using the mega-voltage (MV) x-ray treatment beam, two-dimensional projection images
of the patient can be acquired with film or digitally with an electronic portal imaging
device (EPID) [54-56]. The resulting projection images can then be aligned with the
digitally reconstructed radiographs (DRR) generated from the planning CT datasets [57].
During the comparison process, positions of visible bony landmarks relative to the
radiation field edge are used to verify the tumour position indirectly [58,59]. However,
possibilities still exist for the tumour position to change with respect to the bony
structures [19]. Direct verification of the tumour position can be achieved with the use of
fiducial markers implanted into the tumour volume at the risk of potential surgical
complications, such as pneumothorax [46,47]. Although various technologies have been
available for electronic portal imaging, the majority of the currently available systems
utilize amorphous silicon flat panel imagers (FPI) [54]. The commercial FPI-based
systems include Varian PortalVision (Varian Medical Systems, Palo Alto, CA) and
Elekta iViewGT (Elekta Oncology, Stockholm, Sweden).

1.3.2

Two-Dimensional (2D) kilo-Voltage (kV) Imaging

Projection images exhibiting better contrast can be generated with the use of kilo-voltage
(kV) x-ray sources in the treatment room.

However, direct verification of tumour

position may still require the use of fiducial markers implanted into the tumour volume
[58,59]. Multiple x-ray tubes may be used, so that the orthogonal projection images
produced by the corresponding detectors can be combined to provide some 3D
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information [54]. In the commercially available robotic radiosurgery systems [60,61],
such as BrainLAB Novalis (BrainLAB AG, Feldkirchen, Germany) and Accuray
Cyberknife (Accuray, Sunnyvale, CA), two x-ray tubes are mounted on the ceiling, while
the flat panel imagers are located in the floor. Conversely, the system developed by the
Shirato group utilizes four floor-mounted x-ray tubes and x-ray image intensifiers
installed on the ceiling [62-64].

1.3.3

Three-Dimensional (3D) kilo-Voltage (kV) CT Imaging

Direct 3D imaging of soft tissues can be achieved by performing CT imaging inside the
treatment room. In the “CT-on-rails” approach, a separate CT scanner is installed inside
the treatment room, such that the treatment couch can be shared between the treatment
unit and the CT scanner [65,66]. The commercial systems include Varian ExaCT (Varian
Medical Systems, Palo Alto, CA), and Siemens Primatom (Siemens AG, Erlangen,
Germany).
The existing linear accelerator can also be modified to incorporate cone beam CT
(CBCT) imaging, where an additional kV x-ray tube is mounted orthogonal to the gantry
head to rotate with the gantry, sharing the same axis of rotation [67-71]. By employing a
cone beam geometry that covers the entire region of interest within the patient, a 3D CT
image can be acquired in a single rotation. However, the increased scattered x-rays
generated due to the large field size must be accounted for to obtain better quality and
quantifiable CT number data for dose computations. The commercial linear accelerators
equipped with the CBCT system include Elekta Synergy (Elekta Oncology, Stockholm,
Sweden), Varian On-Board Imager (OBI) (Varian Medical Systems, Palo Alto, CA), and
Siemens Artiste (Siemens AG, Erlangen, Germany). These commercial systems also
provide electronic portal and kV-fluoroscopic imaging capabilities. Alternatively, the
linear accelerator can also be designed to generate both kV and MV x-ray beams from the
same source position. In the Siemens Artiste system (Siemens AG, Erlangen, Germany),
the kV beam is generated by utilizing a carbon target instead of tungsten target, while
retracting the beam flattening filter.
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1.3.4

Three-Dimensional (3D) Mega-Voltage (MV) CT Imaging

Cone Beam CT (CBCT) imaging can also be performed with the treatment MV x-rays,
requiring fewer modifications to the existing linear accelerator design [72-76].

An

example of such system is Siemens MVision (Siemens AG, Erlangen, Germany). As
noted previously, helical tomotherapy is capable of providing MVCT imaging, using a
fan beam similar to that of the diagnostic CT units. With a gantry rotation period of 10 s
[39], the current TomoTherapy Hi-Art II system (TomoTherapy Inc., Madison, WI)
offers three different MVCT acquisition modes with slice spacing of 6 mm (coarse), 4
mm (normal), and 2 mm (fine) [77-79].

1.3.5

Real-Time Tumour Tracking Methods

The 2D-kV imaging system described in Section 1.3.2 can be used to directly monitor the
tumour position in real-time. Projection images are acquired periodically during the
treatment to track the fiducial markers implanted into the tumour volume [60-64].
However, this approach is not applicable for helical tomotherapy, due to the ring gantry
configuration of the tomotherapy machine restricting the access of the fluoroscopic tubes.
Direct monitoring of the tumour volume can also be carried out without the use of
radiation. With the Calypso system (Calypso Medical Technologies, Inc., Seattle, WA),
electromagnetic transponders implanted into the tumour volume are tracked
electromagnetically by the localization array panel mounted onto the treatment couch
[80,81]. The relatively compact size of the localization array panel also makes the use of
the Calypso system feasible for all radiotherapy machines, including helical tomotherapy.
The tumour volume can also be monitored indirectly in real-time by tracking a tumour
surrogate that represents the tumour position. The examples of tumour surrogates include
chest or abdominal motion, lung volume and/or speed of air flow measured by spirometry
[82,83], or pressure measured by an abdominal strain gauge [84]. In the Real-time
Position Management (RPM) system (Varian Medical Systems, Palo Alto, CA), the
movement of an infrared reflective plastic box placed on patient’s chest or abdomen is
monitored by an in-room camera. A commercial example of an abdominal strain gauge
is the fixation belt used for the AZ-733V respiratory gating system (Anzai Medical Co.,
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Ltd, Tokyo, Japan), that is wrapped around the patient abdomen.

The resulting

abdominal pressure changes are then measured with a pressure sensor attached to the
fixation belt. Although indirect monitoring removes the surgical complication risks of
implanting fiducial markers, an accurate correlation must be established between the
actual tumour position and the tumour surrogate. In addition, one must ensure that the
same correlation is being maintained throughout the course of treatment. The internalexternal correlation between the tumour position and tumour surrogate may be verified
with the use of 4D-CT imaging [85-89].

1.3.6

Future Outlook

Currently, both the CBCT and MV imaging techniques are being used only for geometric
verification of the tumour position. The next step would be to perform dose calculations
using the acquired CT data, to determine whether the planned dose distribution is being
delivered to the tumour volume, and if the existing plan needs to be re-optimized during
the course of treatment.

However, the CT numbers generated by these imaging

modalities are not yet reliable enough for dosimetric adaptations [90-96]. With the use of
four-dimensional (4D) CT imaging [85-89] becoming more prevalent for treatment
planning, employing a four-dimensional (4D) image guidance technique may become a
clinical practice of the future. Direct comparisons could then be made between the
planning 4D-CT and 4D-CBCT images generated at the same phase of the respiratory
cycle [97]. A MRI system may also be incorporated into the linear accelerator to provide
superior soft tissue contrast, while avoiding the need for giving additional radiation dose
to the patient.

However, significant technological hurdles still remain, such as the

interference between the electromagnetic fields of the linear accelerator and the MRI
system [98,99].

1.4 Tumour Motion and Motion-Induced Dose
Discrepancies
Tumour motion resulting from patient breathing is a significant problem for lung
radiotherapy. It forces the clinicians to use a larger margin around the tumour volume, in
an effort to encompass the full extent of tumour motion. As a result, a significant volume
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of surrounding normal lung tissues is irradiated, increasing radiation toxicities and
placing a limit on the maximum dose that can be prescribed to the tumour volume. In
addition, the presence of tumour motion during dose delivery can produce dose
discrepancies between the planned and delivered dose distributions to the tumour volume,
affecting the accuracy of dose delivery. These major issues caused by tumour motion can
compromise the clinical benefits of radiotherapy and lead to suboptimal local tumour
control of lung cancer. In this section, the mechanics of breathing and extent of lung
tumour motion will be described, as well as the impact of tumour motion for different
radiation treatment modalities, including helical tomotherapy.

1.4.1

Mechanics of Breathing

Breathing is a physiological process alternating between inspiration and expiration to
facilitate gas exchanges between blood and air inside the lungs. Lungs are located within
the thoracic cavity, surrounded by a fluid-filled pleural cavity. The inner membrane of
the pleural cavity envelops the lungs, while its outer membrane is attached to the thoracic
wall, holding the lungs in place. Due to this unique anatomical arrangement, volume of
the thoracic cavity directly affects the pressure inside the pleural cavity (intrapleural
pressure) and the lungs (alveolar pressure). During breathing, the alveolar pressure varies
from being slightly below or above the atmospheric pressure, causing the air to either
flow in or out of the lungs. On the other hand, the intrapleural pressure always remains
far below the atmospheric pressure to keep the lungs from collapsing [20].
During inhalation, the expansion of the thoracic cavity occurs in all dimensions, driven
by the active contractions of the diaphragm and the intercostal muscles connecting the
ribs. The superior-inferior (SI) dimension of the thoracic cavity is expanded with the
diaphragm descending inferiorly, while the contracting intercostal muscles pull the ribs
superiorly and anteriorly to increase the anterior-posterior (AP) and lateral diameters of
the thoracic cavity. The thoracic cavity expansion is then accompanied by a volumetric
increase of the pleural cavity, and a simultaneous decrease in intrapleural pressure. Due
to the decrease of pressure just outside the lungs, the lungs also undergo volumetric
expansions, causing the alveolar pressure inside the lungs to drop below the atmospheric
pressure. Thus, air is drawn into the lungs, until the alveolar pressure reaches the
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atmospheric pressure. During the exhalation, both diaphragm and intercostal muscles
passively return to their pre-inhalation states, restoring the previous lung volume and
pressure, pushing air out of the lungs. The complex elastic property of the lung also
contributes to its volume-pressure relationship exhibiting hysteresis, where the inhalation
lung volume is always smaller than the exhalation lung volume at the same
transpulmonary pressure, i.e. the difference between the alveolar pressure and
intrapleural pressure [100]. In relations to dose computations and dose delivery, the lung
is a complex dose absorber due to its variable shape and density.

1.4.2

Measurements of Tumour Motion

Various studies have employed different imaging modalities, such as fluoroscopy, CT
and MRI to investigate tumour motion at different locations with the lung (upper, middle
and lower lung) [19,20]. Fluoroscopy techniques included film radiography, MV portal
imaging, and kV fluoroscopy, with and without the use of fiducial markers. Parameters
of lung tumour motion, such as magnitude, period, regularity, and baseline variation were
shown to vary widely between individual patients. Although it was difficult to establish a
strong correlation between tumour displacement and tumour location within the lung, the
greatest 3D tumour displacements were observed for the lower lung tumours, due to the
influence of diaphragmatic motion. Mean displacements of up to 18.5 mm, 7 mm, and
12.6 mm were reported in the superior-inferior (SI), anterior-posterior (AP), and left-right
(LR) direction, respectively [19-21]. Thus, proximity of the tumour position to the
diaphragm may serve as a strong indicator for the presence of predominant SI tumour
motion. In some studies, the diaphragm position was used as the tumour surrogate for
monitoring, due to the difficulty of viewing the actual tumour volume [101-104]. For
lower and middle lung tumours, the displacements of up to 38.7 mm and 26.1 mm were
observed in the SI direction [21].

However, the largest tumour displacement was

reported for an upper lung tumour, which exhibited a displacement of up to 50 mm in the
SI direction [19].
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1.4.3

Motion-Induced Dose Discrepancies for Helical Tomotherapy

The presence of tumour motion during dose delivery can lead to significant dose
discrepancies between the planned and delivered dose distributions. This motion-induced
dosimetric problem may not be simply resolved by assigning a larger margin around the
tumour volume, as the dose distribution within the tumour volume and surrounding
region is being affected.

Thus, it becomes crucial to understand the relationships

between the treatment and tumour motion parameters, and discover ways to minimize the
magnitude of overall dose discrepancies.
Motion-induced dose discrepancies have been reported in the literature for different
IMRT techniques. The interplay between the MLC motion and tumour motion prevent
the intended dose distribution from being delivered to the tumour volume, as the interplay
effect is not modelled during treatment planning [49,50,105,106]. The problem becomes
even more complicated for helical tomotherapy, which employs three simultaneously
moving subsystems (gantry, couch, and b-MLC). As a result, possibilities for a greater
number of interplay and interactions with tumour motion can exist. The impact of
tumour motion during helical tomotherapy has been studied [49,107-109].

Gradual

changes in amplitude, period, and baseline of tumour motion over a period of time were
also shown to generate significant dose discrepancies [110,111].
However, no work has yet to isolate and systematically categorize the different types of
dose discrepancies resulting from tumour motion during helical tomotherapy. Different
types of motion-induced dose discrepancies should be investigated individually, in
relations to different treatment and tumour motion parameters to gain better
understanding for their causes. Once a clear understanding for all potential types of dose
discrepancies is established, the appropriate strategies to address these effects can be
proposed and investigated.

Study of different types of motion-induced dose

discrepancies due to tumour motion during helical tomotherapy is one of the most
essential components of this thesis.2

2

Different motion-induced dose discrepancies investigated in this thesis are summarized in Table 5.1.
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1.5 Motion Management of Lung Tumours during Radiation
Delivery
In this section, both the traditional and new methods of defining motion-encompassing
tumour volume will be discussed. The different motion management techniques will then
be described for both conventional radiotherapy techniques and helical tomotherapy.

1.5.1

Use of Margins to Encompass Tumour Motion

Traditionally, target volume delineation process follows the guidelines provided by the
ICRU 62 [112]. A gross tumour volume (GTV) is defined as “the gross demonstrable
extent and location of the malignant growth” that is visible on the planning images [98].
A clinical target volume (CTV) expands on the GTV to include microscopic extensions
surrounding the GTV, which are invisible on the images but nonetheless exist.

A

planning target volume (PTV) is then produced by adding a margin around the CTV to
account for all sources of intrafraction and interfraction uncertainties arising over the
course of a radiation treatment. There are a number of PTV margin “recipes” currently
available, which propose the different weighting factors for the various systematic and
random components of uncertainties to calculate the required PTV margin size [113].
In the presence of tumour motion, the PTV margin may be further divided into internal
margin (IM) and set-up margin (SM).

An internal margin (IM) encompasses the

intrafraction tumour motion, and interfraction variations of the CTV size, shape and
position. A set-up margin (SM) accounts for the patient set-up and beam positioning
uncertainties.

One of the currently available image guidance methods discussed in

Section 1.3 may be employed to minimize the PTV margin size.
With the availability of more advanced imaging techniques, however, a new way of
defining GTV to encompass tumour motion has emerged. This motion-encompassing
tumour volume may be referred to as the tumour motion envelope [114], or the internal
gross tumour volume (IGTV) [115-119]. The philosophy behind this approach is to
commence the tumour delineation process with a “correct” GTV, rather than accounting
for tumour motion using internal margin (IM) at a latter stage. “Slow” CT imaging
utilizes a gantry rotation period comparable to a tumour motion period to capture the

18

entire motion extent of a tumour volume [120-122]. The slow CT scan is performed
multiple times to ensure that the resulting tumour motion envelope represents the sum of
tumour volumes at all of its probable positions. Due to the use of a relatively slow gantry
speed and large amount of data, however, the resulting slow CT images are subjected to
significant motion-induced image artifacts, interfering greatly with an accurate
delineation of the tumour envelope [114,123-125]. Gagne et al has demonstrated that the
tumour envelope can still be determined accurately in the presence of image artifacts by
only accepting a volume of pixels with intensity above a specific threshold [105].
With the advent of 4D-CT imaging technique, multiple CT datasets at different
respiratory phases have become available clinically [85-89]. Thus, the GTV’s contoured
from all respiratory phases can be combined to generate an internal gross tumour volume
(IGTV). Currently, at London Regional Cancer Program (LRCP), contouring is done at
the end-expiration and end-inspiration phases to capture the tumour volume at its most
extreme positions. The two GTV’s are then combined with the GTV contoured on the
“average” CT of all phases to generate the IGTV. It has been shown that the IGTV
produced from the end-expiration and end-inspiration phases alone may significantly
underestimate the IGTV generated from all phases [119]. Alternatively, the IGTV can
also be delineated on the maximum intensity projection (MIP) image from the different
phases [116-119]. However, the MIP approach is not capable of isolating the tumour
volumes that are located close to other structures, such as the diaphragm or mediastinum
[116].

1.5.2

Tumour Motion Management for Conventional Radiotherapy
Techniques

Accurate determination of the planning target volume (PTV) encompassing the entire
tumour motion alone is not sufficient to account for the motion-induced dose
discrepancies generated inside the PTV. Thus, employing tumour motion management
will be required to reduce the magnitude of dose discrepancies. The currently available
motion management techniques can be classified into breath-holding, respiratory gating,
and tumour tracking.
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1.5.2.1

Breath-Holding

During a radiation treatment employing breath-holding, treatment beam is only turned on
during breath-holds, and turned off between breath-holds to allow patients to resume
normal breathing. Patients undergo breath-holding at a planned respiratory phase, during
which the tumour volume is temporarily immobilized inside the treatment field [126-139].
To achieve breath-holding in a reproducible manner, patients are provided with assistance
in the form of verbal instructions [130], a breathing-aid such as the active breathing
control (ABC) device [131-135], a visual display of the patient’s own respiration trace
[82,83], or different combinations of these aids.
The respiratory phase for breath-holding may occur at deep-inspiration [126-134], normal
inspiration [136,137], or end-expiration [131,138]. Deep-inspiration breath-holding has
generally shown to yield high tumour position reproducibility, and displace the critical
structures within the thoracic cavity, such as the heart and major blood vessels, away
from the treatment field. In addition, the total mass of normal lung tissues within the
treatment field may decrease, as the lung tissue density approaches its minimum at deepinspiration. However, patient discomfort remains a big issue for breath-holding, due to
the poor pulmonary conditions of lung patients. At Memorial Sloan-Kettering Cancer
Center (MSKCC), a compliance rate of only 40% was reported for deep-inspiration
breath-holding in 2000 [127].

Patient compliance rate may improve with normal

inspiration breath-holding, but the aforementioned clinical advantages of deep-inspiration
breath-holding may be greatly reduced. With end-expiration breath-holding, tumour
coverage may improve due to the increased lung tissue density, but at the expense of
greater mass of normal tissues being irradiated. However, it has been shown that the
improved lung tissue sparing at deep inspiration is likely to outweigh the improved
tumour coverage at end-expiration [139].
Due to the patient compliance issue for breath-holding, forced shallow breathing (FSB)
may be employed to allow limited normal breathing [140-143].

In this approach,

pressure is applied to the patient’s abdomen by a small plate attached to a stereotactic
frame, thus limiting the extent of diaphragmatic motion. Negoro et al has observed the
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range of tumour motion to decrease from 8-20 mm (12.3 mm mean) to 2-11 mm (7.0 mm
mean) with abdominal compression [142].

1.5.2.2

Respiratory Gating

During a radiation treatment employing respiratory gating, the treatment beam is only
turned “on” during a pre-determined portion of a tumour motion cycle, placing no
constraints on patient breathing. This pre-set portion of a tumour motion cycle, namely
the gating window, may cover a range of tumour positions (amplitude gating) or phases
within a respiratory cycle (phase gating), during which radiation delivery is enabled [144148]. Once the tumour volume moves out of the gating window, the treatment beam is
turned off, until it returns again inside the gating window for a subsequent beam delivery.
As the magnitude of tumour motion during radiation delivery becomes restricted to the
residual motion [148] within a gating window, the impact of tumour motion during a
gated dose delivery is greatly reduced.
Selecting an appropriate gating window size is based on a tradeoff between accuracy and
efficiency of dose delivery. Use of a very small gating window will effectively “freeze”
the tumour motion during radiation delivery, allowing for an accurate dose delivery to be
made to the tumour volume.

However, this occurs at the expense of significantly

prolonging the treatment session time. The gating window is normally positioned around
the end-expiration phase, as a moving tumour volume typically slows down during
expiration and reaches its minimum velocity at the end-expiration. Thus, placing a gating
window around the end-expiration phase yields a smaller residual motion, compared to
other respiratory phases [144].

1.5.2.3

Tumour Tracking

During a radiation treatment employing tumour-tracking, the moving tumour volume is
continuously irradiated by dynamically moving a treatment beam according to tumour
position [149-155]. As a result, no constraints are placed on patient breathing, and unlike
breath-holding and respiratory gating, the treatment session time is comparable to a
radiation treatment session time without motion management. Beam repositioning may
be achieved through the use of a dynamic MLC [149-154], or a robotic arm [155] moving
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a miniature linear accelerator. In the remainder of this thesis, the MLC repositioning
method will be referred to as the tumour tracking method.
Clinical implementation of tumour tracking dose delivery requires the use of a real-time
tumour monitoring system (Section 1.3.5), and a predictive algorithm [156-161]. A
predictive algorithm is used to anticipate the “near-future” tumour position in advance,
accounting for the time required to determine and execute appropriate MLC movements
after detecting the tumour location. For a conventional MLC system, the leaf response
latency and the actual leaf transition time combine to yield a total latency in the range of
100-200 ms [20].

Thus, the accuracies of tumour monitoring and the predictive

algorithm become crucial to ensure an appropriate synchrony is established between
tumour motion and corresponding leaf actions, so that significant dose discrepancies can
be avoided.

1.5.3

Tumour Motion Management for Helical Tomotherapy

Employing any of the aforementioned motion management techniques in Section 1.5.2
becomes more complicated for helical tomotherapy, due to its continuously moving
subsystems (gantry, couch, and b-MLC). In the past, different motion management
methods [162-167] have been proposed for helical tomotherapy, but none of them have
been implemented clinically as of yet.
In the “gating-by-rotation” approach, dose delivery during each gantry rotation occurs,
while the patient undergoes breath-holding. Each gantry rotation with breath-holding is
then followed by a “non-treatment” gantry rotation, during which the couch movement is
temporarily halted and the b-MLC leaves remain fully closed to permit normal breathing
[162,163]. At the start of the subsequent gantry rotation, both breath-holding and couch
motion resume for dose delivery. The same process is repeated, until the entire tumour
volume is treated.
Tumour motion information may be incorporated a priori during the plan optimization
process, allowing for a pre-planned tracking of the tumour volume by the binary MLC (bMLC) during treatment [164,165]. However, the same tumour motion pattern used
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during planning must be reproduced during each treatment fraction to avoid significant
dose discrepancies.

Real-time tumour tracking has also been proposed for helical

tomotherapy [166,167].

In this method, the longitudinal motion component is

compensated by “shuffling” and executing the sequence of planned beam projections
assigned with the same gantry angles out-of-order, according to the detected longitudinal
tumour location. The change in lateral tumour position is accounted for by delivering the
same planned fluence through different leaves.

1.5.4

Limitations of the Proposed Tumour Motion Management
Approaches for Helical Tomotherapy

With the “gating-by-rotation” approach, halting the couch motion during treatment
introduces an additional couch position uncertainty and potential beam junctioning, as
well as potentially altering the patient position. Although the couch position uncertainty
introduced during each stoppage may be small, the uncertainty accumulated over multiple
start-stops may become significant. The use of a large pitch factor to reduce or eliminate
the interruptions of couch movement may be more feasible clinically, and this becomes
another objective of this thesis.
Although incorporating tumour motion information during the plan optimization process
is an innovative way to track the tumour volume in a pre-planned manner, it will be very
difficult to reproduce the identical tumour motion pattern during each treatment fraction.
For real-time tumour tracking method, “shuffling” the beam projections to treat the
different slices within the volume out-of-order does not compensate for the radiological
pathlength differences encountered by the original and shifted beam projections. As each
spatially shifted beam projection encounters different tissue density and thickness, the
beam attenuation will be affected, preventing the intended dose from being delivered to
the tumour volume – especially for large amplitudes of tumour motion. This tissue
attenuation issue may be avoided by employing respiratory gating over tumour tracking.
Feasibility study of respiratory gating for helical tomotherapy is one of the primary
objectives of this thesis.
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Due to the continuous motions of the gantry and treatment couch during helical
tomotherapy, the dose undelivered at a particular gantry angle and couch position cannot
be recovered, unless the gantry rotation and couch motion are interrupted. The only way
to make up for the “missing” dose without introducing treatment interruptions is to repeat
the entire treatment. Thus, the two new approaches presented in the current thesis utilize
multiple passes of helical tomotherapy dose delivery to complete the planned dose
distribution to the tumour volume.

1.6 Research Objectives
The research work done in this thesis was focused on the following objectives:
1.

Define the different types of dose discrepancies resulting from tumour motion
during helical tomotherapy, and investigate the characteristics of each dose
discrepancy individually, in relations to different treatment and tumour motion
parameters, through computer simulations and experimental measurements using
film dosimetry.

2.

Describe and investigate the dosimetric characteristics of the loose helical
tomotherapy delivery with breath-holding, simulated on a linear accelerator (prior
to the arrival of the helical tomotherapy unit at LRCP), through treatment planning
and experimental measurements using film dosimetry.

3.

Describe and investigate the feasibility of employing multi-pass respiratory gating
technique for helical tomotherapy, through computer simulations and experimental
measurements using film dosimetry on the helical tomotherapy machine.

1.7 Research Hypothesis
Respiratory gating or breath-holding techniques can be applied to helical tomotherapy to
reduce the different sources of dose discrepancies caused by tumour motion.
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1.8 Scope of the Thesis and Thesis Roadmap
Target volume investigated in this thesis work represents a lower lung tumour located
close to the diaphragm, thus exhibiting predominant motion along the superior-inferior
(SI) direction, driven by diaphragmatic motion. Thus, all motion patterns investigated in
this thesis displayed 1D target motion, only along the SI direction. All the experimental
measurements were performed with sinusoidal target motion, while both sinusoidal and
non-sinusoidal motion patterns were employed for computer simulations.

No

inhomogeneity was introduced by assuming a target volume that is surrounded by waterequivalent tissues, instead of lung tissues.
In Chapter 2: “Motion-induced dose artifacts in helical tomotherapy”, the different types
of dose discrepancies resulting from tumour motion during helical tomotherapy are
defined, and their characteristics are investigated individually, in relations to different
treatment and tumour motion parameters.

The work in this chapter is based on a

publication, “Kim B, Chen J, Kron T, and Battista J (2009) Motion-induced dose artifacts
in helical tomotherapy. Phys Med Biol 54, 5707-34.” In Chapter 3: “Investigation of
dose homogeneity for loose helical tomotherapy delivery in the context of breath-hold
radiation therapy”, the loose helical tomotherapy delivery with breath-holding is
described, along with its dosimetric characteristics. The work in this chapter is based on
a publication, “Kim B, Kron T, Battista J, and Van Dyk J (2005) Investigation of dose
homogeneity for loose helical tomotherapy delivery in the context of breath-hold
radiation therapy. Phys Med Biol 50, 2387-404.” In Chapter 4: “Feasibility study of
multi-pass respiratory-gated helical tomotherapy of a moving target via binary MLC
closure”, the multi-pass respiratory gating technique is described.

The proposed

technique is investigated, in terms of its effectiveness for reducing the magnitude of
different motion-induced dose discrepancies described in Chapter 2. The work in this
chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista J (2010)
Feasibility study of multi-pass respiratory- gated helical tomotherapy of a moving target
via binary MLC closure. Phys Med Biol 55, 6673-94.” In Chapter 5: Summary and
Conclusions, major findings from each of Chapter 2, 3, and 4 are summarized. The
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clinical implications and the limitations of the proposed methods and the work done in
this thesis are discussed, as well as the future work.
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Chapter 2

2

Motion-Induced Dose Artifacts in Helical Tomotherapy

The work in this chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista
J (2009) Motion-induced dose artifacts in helical tomotherapy. Phys Med Biol 54, 570734.” http://dx.doi.org/10.1088/0031-9155/54/19/004

2.1 Introduction
2.1.1

Helical Tomotherapy

Helical tomotherapy [1,2] is a novel radiation therapy technique, which utilizes a
continuously rotating gantry and a linearly moving couch to irradiate a target volume in a
helical manner.

As the treatment couch advances into the gantry bore along the

longitudinal direction (Y), the target volume is irradiated in slices using a fan beam of
radiation.

At the axis of gantry rotation (SAD = 85 cm), a two-stage collimation

produces a fan beam field with a projected width of 40 cm (X = 40 cm) and a selectable
fan beam thickness of 1.05 cm, 2.5 cm, or 5.0 cm along the longitudinal direction (Y).
The fan beam is further divided into 64 beamlets with each beamlet being 0.625 cm wide
at the axis of gantry rotation (40 cm / 64 = 0.625 cm), using a binary multi-leaf collimator
(b-MLC). The b-MLC consists of 64 interlaced binary leaves (32 on each side of the axis
of gantry rotation), which can be either fully open or fully close with a leaf transit time of
about 15 ms [3,4]. Radiation fluence passing through each beamlet is thus controlled by
the duration of time for which its corresponding leaf remains open (i.e. leaf opening
time). Every gantry rotation during a helical tomotherapy treatment is divided into 51
equally-spaced beam projections (each spanning ~70) for the purpose of intensity
modulation. Intensity modulation is then achieved by assigning a specific value of leaf
opening time as a function of beam projection and leaf number. The duration of leaf
opening time is centered about the mid-point of each beam projection period, with the
leaf remaining closed during the start and end of the beam projection period.
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2.1.2

Tumour Motion

The presence of tumour motion during the radiation therapy of lung cancer is a welldocumented problem. In the past, various approaches have been proposed to minimize
the effect of respiratory-driven tumour motion during conformal radiation therapy [5-8],
IMRT [9,10], and helical tomotherapy [4,11-13] treatments. Inferiorly positioned lung
tumours typically exhibit the greatest range of motion along the superior-inferior (SI)
direction of the patient, due to their proximity to the diaphragm and the resulting
influence of the diaphragmatic motion. Peak-to-peak magnitude of such tumour motion
can approach several cm’s with a typical period of 3-5 s [14-17].

The SI motion

component coincides with the longitudinal direction of the couch motion, and thus
interferes directly with the “slice-to-slice” irradiation of the target volume during a
tomotherapy delivery. This motion-induced interference can lead to various types of
dose discrepancies between the delivered and plan dose distributions [18-21]. Dose
discrepancies can also result from the anterior-posterior (AP) and left-right (LR)
components of tumour motion. Although the correct slices of the target volume are still
being irradiated in the presence of these motions, the plan dose is not correctly deposited
in the planning target volume (PTV). In this work, however, we will be focusing on the
SI target motion only, as it is the predominant motion component that can potentially
produce the most significant dose discrepancies.

2.1.3

Different Types of Motion-Induced Dose Discrepancies

In the present study, three different types of motion-induced dose discrepancies are
defined specifically for helical tomotherapy, namely (1) dose rounding, (2) dose rippling,
and (3) IMRT leaf opening asynchronization effect.

Dose rounding [18,21] is the

penumbral widening of a delivered dose distribution near the edges of a target volume
along the direction of tumour motion. In the presence of longitudinal target motion, the
penumbral increase leads to the under-dosing of the target volume near its longitudinal
boundaries, and over-dosing of the surrounding normal structures just outside the target
volume. Dose rounding becomes more pronounced with the increasing amplitude of
tumour motion.
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Dose rippling [18-20] is a series of periodic dose peaks and valleys present within the
target region along the direction (Y) of couch motion. Dose rippling is observed for
tomotherapy cases both with and without intensity modulation (i.e. IMRT and non-IMRT
cases). Dose rippling occurs due to an asynchronous interplay between the couch motion
and the longitudinal tumour motion with a fixed frequency. When the interplay is
synchronous, dose rippling becomes absent for the non-IMRT cases, while being
significantly reduced for the IMRT cases.

For the non-IMRT cases, constant leaf

opening time means that the dose losses due to motion are always compensated by the
identical dose gains (and vice versa) for synchronous conditions, which leads to the
absence of dose rippling. On the other hand, the variable durations of leaf opening time
during an IMRT delivery cause the dose gains to differ from the dose losses. Thus,
although the magnitude of dose rippling is significantly reduced for synchronous
conditions, the differences still exist between the planned and delivered dose
distributions.
The IMRT leaf opening asynchronization effect is an additional effect caused by an
asynchronous interplay between the temporal patterns of leaf openings and the
longitudinal target motion.

Unlike dose rippling, the IMRT leaf opening

asynchronization effect does not exhibit any periodicity, and its resulting dose
distribution pattern is highly specific and unique to each tomotherapy plan (i.e. leaf
opening pattern). The paper by Kanagaki et al [21] was the only study that investigated
the effect of tumour motion for IMRT helical tomotherapy deliveries. However, the
IMRT leaf opening asynchronization effect was not observed in this particular work, and
hence we characterized a new and significant dose discrepancy associated with IMRT
tomotherapy deliveries.

2.1.4

Purpose

In the present study, the characteristics of the three aforementioned dose discrepancies
were investigated as functions of target motion amplitude and period for both non-IMRT
and IMRT helical tomotherapy cases in the presence of sinusoidal target motion. The
non-IMRT cases were investigated to allow for the dose rounding and dose rippling
effects to be studied separately.

A computer simulation model was developed to

40

calculate longitudinal dose profiles along the axis of gantry rotation inside a body
phantom, and to be used as a tool to predict the dosimetric effect of tumour motion
during a helical tomotherapy delivery. Experimental verification was then carried out on
the helical tomotherapy unit, using a motion body phantom and dosimetric film. The
dosimetric characteristics of dose rounding and dose rippling were also studied as a
function of target motion amplitude.

2.2 Materials and Methods
2.2.1

Helical Tomotherapy Plans

In this section, the parameters related to helical tomotherapy and tumour motion will be
defined. The nature of leaf opening sinogram will be explained. The non-IMRT and
IMRT helical tomotherapy plans used in this study to investigate the effect of target
motion will be also described.

2.2.1.1

Helical Tomotherapy and Tumour Motion Parameters

The treatment parameters associated with helical tomotherapy include pitch factor (p),
fan beam thickness (b), gantry rotation period (Tg), and number of gantry rotations (R).
Pitch factor (p) is defined as the progression distance of the longitudinal couch motion
per gantry rotation in units of fan beam thickness (b). Gantry rotation period (Tg) is the
time required to complete one full gantry rotation; the current helical tomotherapy unit
allows for selectable periods (Tg) between 15 and 60 s, with a gantry rotation period of 15
to 20 s being used clinically for the helical tomotherapy of lung cancer [22]. Number of
gantry rotations (R) is the number of gantry rotations required to treat the target volume
during the treatment. The parameters related to tumour motion are amplitude (A) and
period (Tr). Amplitude (A) is defined as the one-half of the peak-to-peak amplitude (2A)
of tumour motion along the longitudinal direction (+Y), while tumour motion period (Tr)
is the time required to complete one full cycle of tumour motion.

2.2.1.2

Leaf Opening Sinogram

During a helical tomotherapy treatment, intensity modulation is carried out according to
the leaf opening time information stored in the form of a leaf opening sinogram. The leaf
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opening sinogram is a two-dimensional matrix of leaf opening time values, where the row
and column indices represent leaf number and beam projections, respectively. In this
study, a user-created leaf opening sinogram was utilized for the non-IMRT cases, while a
leaf opening sinogram for the IMRT cases was generated by the helical tomotherapy plan
optimizer (TomoTherapy version 2.2.2, TomoTherapy Inc., Madison, WI).

2.2.1.3

Non-IMRT Helical Tomotherapy Plan

The current helical tomotherapy unit (HI-ART II) allows the user to enter a leaf opening
sinogram directly at the treatment console for a radiation delivery. In order for the leaf
opening sinogram to be accepted at the treatment console, the leaf opening sinogram
must contain values of relative leaf opening time. Relative leaf opening time (T0) is
defined as the ratio of the actual leaf opening time (Ta) for a beam projection to the
maximum leaf opening time per beam projection (Tm):
T0 =

Tg
Ta
, Tm =
Tm
n

(2.1)

where T0 is the relative leaf opening time for a beam projection, Ta is the actual leaf
opening time for the beam projection, Tm is the maximum leaf opening time per
beam projection, Tg is the gantry rotation period, and n is the number of beam
projections per gantry rotation (n = 51).
For the non-IMRT plan, the planning target volume (PTV) was assumed to be a 5.5 cmlong cylinder centered along the axis of gantry rotation inside the body phantom (Modus
Medical Devices Inc., London, Canada) shown in Figure 2.1 a), which mimicked a
human torso. The four central leaves were assigned with the maximum leaf opening time
(T0 = Tm = 1.00) for all beam projections, while the rest of the leaves remained fully
closed (T0 = 0.00) during the entire treatment, using a fan beam thickness (b) of 2.5 cm.
A fixed value of leaf opening time was assigned for each individual leaf, so that a
uniform fluence was delivered only along the central axis of the PTV. Using a pitch
factor of 0.8 (p = 0.8), four full gantry rotations (R = 4) were required to treat the PTV,
and a gantry rotation period of 16 s (Tg = 16 s) was selected. A pitch factor of 0.8 was
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selected rather than the typically used pitch factor of less than 0.3 for lung cancer
tomotherapy [22], in order to produce specific conditions for studying the dose rippling
effect described in Section 2.1.3.

2.2.1.4

IMRT Helical Tomotherapy Plan

An IMRT helical tomotherapy plan was generated using the CT images of a body
phantom (ρ = 1.18 g/cm3, length = 12 cm, width = 30 cm, height = 20 cm) in Figure 2.1
a).

On the CT images of the body phantom (Figure 2.1 b), a virtual 3.6 cm-long

cylindrical organ at risk (OAR) was delineated to be wrapped around by a 6.6 cm-long Cshaped planning target volume (PTV).

Contouring of the PTV, the OAR, and the

phantom outline was performed in a commercial treatment planning system (Pinnacle
8.0d, Philips Medical Systems). The CT images and contours were then exported to the
tomotherapy treatment planning system (TomoTherapy version 2.2.2, TomoTherapy Inc.,
Madison, WI), where a dose of 2.0 Gy was prescribed to 95 % of the PTV with the
maximum OAR dose being limited to 0.8 Gy. A pitch factor (p) of 0.287 (i.e. 0.86 / 3)
was selected to minimize the “thread artifact” [23], and a fan beam thickness of 2.5 cm
was chosen.

During the tomotherapy plan optimization process, the values of leaf

opening time needed to optimize the plan were calculated for each of the 64 b-MLC
leaves as a function of beam projection, yielding the planned dose distribution shown in
Figure 2.1 c).
At the end of the plan optimization, the generated leaf opening sinogram contained sums
of leaf opening time for all fractions of a treatment (i.e. actual leaf opening time per
fraction * number of fractions) over 819 beam projections (R ~ 16), with the matrix rows
and columns representing beam projections and leaf number, respectively. The leaf
opening sinogram was then truncated to shorten the length of the PTV from 6.6 cm to
3.24 cm, so that the resulting PTV region fell well within the length of the body phantom
with the motion amplitudes used in this study. This was done by eliminating the first 252
and the last 159 beam projections, yielding a plan with 408 beam projections (R = 8) and
a plan dose of 1.75 Gy instead of 2.0 Gy. This was deemed acceptable, as the objective
of this study was not to reproduce a particular plan, but to investigate how motion affects
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a given plan. In order to make the modified leaf opening sinogram to be accepted at the
treatment console, each value of leaf opening time was converted to relative leaf opening
time, and the entire leaf opening sinogram matrix was then transposed (i.e. indexed by
leaf number, beam projection).

Figure 2.1: IMRT helical tomotherapy plan for a stationary target a) Photograph of
the lucite body phantom (ρ
ρ = 1.18 g / cm3, length = 12 cm, width = 30 cm, height = 20
cm) mimicking a human torso, b) Transverse (top) and coronal (bottom) CT images
of the body phantom with the contours of the PTV (dark), OAR (light), and the
phantom outline. The film insert remained stationary inside the body phantom at
its mid-position during the CT scanning process. c) Plan dose distributions on the
transverse and coronal planes. Dose of 2.0 Gy was prescribed to 95% of the PTV
with the maximum OAR dose being limited to 0.8 Gy.

3

The delivered dose distribution in Figure 2.7 (b) for the (i) “no motion” case appears different from the
plan coronal dose distribution shown in Figure 2.1 (c), due to the truncation process as well as the resulting
shift in gantry angle.
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2.2.2

Computer Simulation

A computer simulation program was developed in MATLAB (Mathworks, Natick, MA),
as a tool to study and predict the dosimetric effect of longitudinal target motion during a
helical tomotherapy delivery. The computer simulation model was designed to calculate
dose profiles along the axis of gantry rotation for both non-IMRT and IMRT helical
tomotherapy irradiations of the body phantom (Figure 2.1 a). A similar study for helical
tomotherapy was first published by Kissick et al [20], which was an extension of the
work done by Yu et al [19] for the sliding window technique. The concept used by Yu et
al [19] was applicable to the present study and to the study by Kissick et al [20], since the
set-up for the sliding window technique in the presence of lateral motion was analogous
to that of helical tomotherapy in the presence of longitudinal motion. For simplicity, we
investigated the effect of target motion with a sinusoidal pattern, and this model was
general enough to handle any type of motion pattern.

2.2.2.1

Coordinate System

The tumour coordinate system (Figure 2.2 b) was adopted for the computer simulation
model in this study, instead of the room coordinate system (Figure 2.2 a) used by Kissick
et al [20]. In the room coordinate system (Figure 2.2 a), the tumour position, Y(t) is
determined by the linear motion of the treatment couch combined with the periodic
motion of the tumour volume itself:

Y (t ) = Ycouch (t ) + Ytumour (t ) =

p ⋅b
2π
t + A sin
t
Tg
Tr

(2.2)

where Ycouch(t) is the position of the treatment couch as a function of time, Ytumour(t)
is the position of the tumour volume on the treatment couch as a function of time, p
is the pitch factor, b is the fan beam thickness, Tg is the gantry rotation period, Tr is
the period of tumor motion, and A is the amplitude of tumour motion along the
longitudinal (+Y) direction.
In the tumour coordinate system (y) shown in Figure 2.2 b), the tumour volume remains
stationary, while the “moving” treatment field assumes the roles of both couch motion
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and tumour motion. The two fan beam edges, leading beam edge yL (t) and trailing beam
edge yT (t) move along the longitudinal direction (+y) with respect to the center of the
tumor volume according to the following equations:
yT (t ) =

p ⋅b
D b p ⋅b
p ⋅b⋅ R b
2π
2π
−
t + A sin
t− − =
t + A sin
t−
Tg
Tr
Tg
Tr
2 2
2
2

p ⋅b
D b p ⋅b
p ⋅b ⋅ R b
2π
2π
+
y L (t ) =
t + A sin
t− + =
t + A sin
t−
Tg
Tr
Tg
Tr
2 2
2
2

(2.3)

where yT (t) and yL (t) are the positions of the trailing and leading beam edges as
functions of time, respectively, D is the total couch travel during the treatment, and R
is the number of gantry rotations used during the treatment.

Figure 2.2: Coordinate systems for a moving target: a) In the room coordinate
system, the tumour position (Y) with respect to the stationary fan beam is governed
by the linear motion of the treatment couch, combined with the periodic motion of
the tumour volume itself, as summarized in Equation 2.2, b) In the tumor
coordinate system (y), the target volume remains stationary, while the “moving”
treatment field assumes the roles of both couch motion and tumor motion. The two
fan beam edges (trailing beam edge, yT(t) and leading beam edge, yL(t)) move along
the longitudinal direction (+y) with respect to the center of the tumor volume
according to Equation 2.3.
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2.2.2.2

Computer Simulation Model

The dose received by each longitudinal point (y) along the axis of gantry rotation was
determined by first calculating the radiation exposure time. In Figure 2.3, a set of solid
lines observed at each longitudinal position represents the irradiation time (“ON”) of the
corresponding point, while the dotted lines indicate the time spent outside the
longitudinal beam edges (“OUT”). Thus, the radiation exposure time (∆t) was calculated
by summing up the temporal lengths of all solids lines:
m

∆t ( y ) = ∑ ∆t i ( y )

(2.4)

i =1

where ∆t(y) is the radiation exposure time at a given longitudinal position (y), m is
the number of solid lines at each longitudinal position (y), and ∆ti is temporal length
of the ith solid line.
For the non-IMRT helical tomotherapy cases shown in Figure 2.3 a) and b), the irradiated
time (“ON”) was equal to the time spent inside the two fan beam edges (“IN”), since the
radiation beam was fully on during the entire treatment by assigning the maximum leaf
opening time for all beam projections (T0 = 1.00). For the IMRT helical tomotherapy
delivery in Figure 2.3 c), the irradiated time (“ON”) was the temporal overlaps between
the time spent inside the beam edges (“IN”) and the “Beam ON” windows, making “ON”
a subset of “IN”. The widths of the “Beam ON” windows were determined by the values
of leaf opening time assigned as a function of leaf number and beam projection. The
temporal length (∆ti) of each solid line (“ON”) was calculated numerically by comparing
the longitudinal position of the given point to the positions of the beam edges and the
“Beam ON” windows in temporal increments of 1 ms. The radiation exposure time (∑
∆ti) of each point was then determined by summing up the lengths of all the irradiated
time segments (∆ti’s). The radiation exposure time calculation was repeated in spatial
increments of 0.01 cm to produce a radiation exposure time versus position profile.
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Figure 2.3: (a) Position vs. time curves of the longitudinal beam edges for a nonIMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target (Tr = 4 s, A =
0.5 cm) in the tumour coordinate system (y), under a synchronous interplay
condition (β = integer = 5). A set of solid lines observed at each longitudinal position
represents the irradiated time (“ON”) of the corresponding point, while the dotted
lines indicate the time spent outside the longitudinal beam edges (“OUT”). In nonIMRT cases, the irradiated time (“ON”) is equal to the time spent inside the two fan
beam edges (“IN”), since the radiation beam remains fully on during the entire
treatment (T0 = 1.00). The temporal length (∆ti) of each solid line (“ON”) was
calculated numerically by comparing the longitudinal position of the given point to
the positions of the beam edges in temporal increments of 1 ms. The radiation
exposure time (∆t) of each point was then determined by summing up the lengths of
all irradiated time segments (∆ti’s). (b) Position vs. time curves of the longitudinal
beam edges for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a
central target (Tr = 8 s, A = 0.5 cm) in the tumour coordinate system (y), under an
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asynchronous interplay condition (β ≠ integer = 2.5). (c) Position vs. time curves of
the longitudinal beam edges for an IMRT helical tomotherapy (p = 0.287, Tg = 15 s,
R = 8) of a central target (Tr = 8 s, A = 1.0 cm) in the tumour coordinate system (y).
The irradiated time (“ON”) was the temporal overlaps between the time spent inside
the beam edges (“IN”) and the “Beam ON” windows, making “ON” a subset of
“IN”. The widths of the “Beam ON” windows were determined by the values of leaf
opening time assigned as a function of leaf number and beam projection.

The resulting longitudinal exposure time versus position profile was converted directly
into a longitudinal fluence profile by assuming a constant fluence rate. The fluence
profile, Φ(y) was then converted to a longitudinal dose profile, D(y) via one-dimensional
convolution using an empirically determined dose kernel, K(y):
D( y) = K ( y) ⊗ Φ ( y)

(2.5)

where D(y) is the dose profile, K(y) is the dose kernel, and Φ(y) is the normalized
fluence profile.
The normalized fluence profile Φ(y) was assumed to be rectangular in shape along the
direction. The dose kernel, K(y) was then derived using a dose profile along the axis of
gantry rotation, acquired experimentally using Kodak EDR2 film. A piece of film was
placed inside the stationary film insert within the body phantom (Figure 2.1 a), and
irradiated for one full gantry rotation (Tg = 15 s) with the treatment couch remaining
stationary during the radiation delivery.

The dose kernel was a set of exponential

functions resembling the primary beam penumbra equations defined by Cunnigham [24]
and used by a commercial treatment planning system (Theraplan Plus v.3.0, 1998) [25].
The dose profile calculated with the dose kernel, K(y) was fitted manually to the
measured dose profile by continuously varying the coefficient values of the different
parameters in the dose kernel, K(y). The fitting process was repeated until the root-meansquare (RMS) of the absolute differences between the entire calculated and measured
dose profiles was less than 1.2 %.

50

2.2.2.3

Dose Rippling Parameter (β)

Dose rippling was one of the three motion-induced dose discrepancies investigated in this
study. The dose rippling parameter, β was defined as a tool to quantify the presence of
dose rippling by determining the nature of interplay (asynchronous or synchronous)
between the couch motion and tumour motion. The dose rippling parameter, β was
defined as the ratio of the time required (Tg / p) for the couch to travel a distance of one
fan beam thickness (b) to the target motion period (Tr):

β=

(T

g

Tr

p)

=

Tg
p ⋅ Tr

(2.6)

where p is the pitch factor, Tg is the gantry rotation period, and Tr is the period of
tumour motion.
A synchronous interplay is established when there is an integer number of target motion
cycles completed during the time span Tg / p (i.e. β = integer). 4 For a non-IMRT
tomotherapy delivery, a synchronous condition leads to the uniform irradiation of the
target along the axis of gantry rotation, and thus the absence of dose rippling – proved
mathematically in Appendix A.5 A similar mathematical relationship to Equation (2.6)
was also defined for the sliding window technique in the study by Yu et al [18]. In
Figure 2.3 a), the uniform irradiation of the target under the synchronous condition (β =
5) is indicated by the identical radiation exposure time for the target points, y = -1.8 cm
and 0.5 cm, i.e. ∑∆ti (-1.8) = ∑∆ti (0.5). At the target point, y = -1.8 cm, the temporal
lengths of the five solid lines add up to the sum of the three solid lines at y = 0.5 cm. At
y = -1.8 cm, the dotted line between the first two solid lines is the same length as the
fourth solid line, making them interchangeable with each other in position. The dotted
line between the second and third solid lines is then switched with the fifth solid line due

4

An example of a synchronous interplay condition is shown in Figure 2.5 (b), while an asynchronous
condition is presented in Figure 2.6 (b).
5

The absence of dose rippling under a synchronous condition also applies for periodic, non-sinusoidal
target motion.
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to their identical lengths, overall yielding a single solid line ranging from t = 4.55 s to t =
24.55 s for the radiation exposure time of 20 s, i.e. ∑∆ti (-1.8) = 20 s. At y = 0.5 cm, the
dotted line between the first and second lines could be interchanged with the third solid
line, while the dotted line between the second and third solid lines is switched with the
first solid line. As a result, a single solid line covering from t = 26 s to t = 46 s is
produced for the radiation exposure time of 20 s as well, i.e. ∑∆ti (0.5) = 20 s = ∑∆ti (1.8). In Figure 2.3 b), the asynchronous interplay condition (β ≠ integer = 2.5) results in
the non-uniform radiation delivery to the target volume. This is illustrated by the two
selected target points, y = -2.0 cm and 0.4 cm receiving different radiation exposure, i.e.
∑∆ti (-2.0) ≠ ∑∆ti (0.4), which leads to the presence of dose rippling.

2.2.3
2.2.3.1

Experimental Verification
Motion Body Phantom

A motion body phantom (Modus Medical Devices Inc., London, Canada) shown in
Figure 2.4 was used to verify the simulation results for the non-IMRT and IMRT helical
tomotherapy cases listed in Table 2.1. The motion phantom consisted of a lucite body
phantom (ρ = 1.18 g/cm3, length = 12 cm, width = 30 cm, height = 20 cm), and a
sinusoidally moving lucite film insert (ρ = 1.18 g/cm3, length = 18 cm, diameter = 8 cm)
representing a tumour mass. The film insert was designed to hold a piece of film (length
= 15 cm, width = 6 cm) inside it, and contained five pins at its inside corners (2 at one
corner and 1 at each of the three corners) to generate pinprick landmarks on each film.
These fiducial marks were later used in the data analysis stage to align a pair of scanned
film images for directly comparing the two dose distributions. The film insert was
positioned to move through the central opening of the body phantom, with the film
placed on the coronal plane. The amplitude of the film insert motion was set by adjusting
the position of the translation stage holding film insert. The motion phantom was also
equipped with a “chest-height” platform, whose vertical up-and-down motion represented
the anterior-posterior (AP) motion of a “chest wall”. The “chest-height” platform moved
with an identical period as the film insert. Thus, the period of the film insert motion was
verified by measuring the positions of the optical markers placed on the platform, using
an optical tracking camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz.
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Table 2.1: List of non-IMRT and IMRT helical tomotherapy cases.

Figure 2.4: Experimental verification setup for a moving target. The motion body
phantom (Modus Medical Devices Inc., London, ON) consisted of the lucite body
phantom, and a sinusoidally moving lucite film insert (length = 18 cm, diameter = 8
cm) representing a tumour mass. The film insert was designed to hold a piece of
film (length = 15 cm, diameter = 6 cm) inside it. The motion phantom was also
equipped with a “chest-height” platform that moves with an identical period as the
film insert. The period of the film insert motion was verified by measuring the
positions of the optical markers placed on the platform, using an optical tracking
camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz.

53

2.2.3.2

Calibration of Film Dosimetry

For each film experiment, a calibration procedure was carried out with a 6 MV helical
tomotherapy X-ray beam, using a cylindrical solid water “Cheese” phantom
(TomoTherapy Inc., Madison, WI, length = 18 cm, diameter = 30 cm). A 10” x 12”
EDR2 film was placed inside the phantom, and the couch height was adjusted to position
the film on the isocentrical coronal plane. The calibration procedure delivered eight 3
cm2 square fields with known dose of 30.5 cGy, 65.2 cGy, 100.9 cGy, 128.2 cGy, 159.5
cGy, 188.9 cGy, 215.0 cGy, and 244.4 cGy. The calibration film was processed along
with a blank film to enable background subtraction. The developed films were then
scanned with a Vidar VXR-16 DosimetryPro scanner (Vidar Systems Corporation,
Herndon, VA) and analyzed with the RIT113 V4 software (Radiation Therapy Dosimetry
Software, Colorado Springs, CO). A region of interest (ROI) of 2 cm2 was placed inside
each of the eight different fields on the calibration film and within the blank film. The
average optical density (OD) was then calculated for each ROI to generate an OD versus
dose calibration curve.

2.2.3.3

Radiation Delivery

All the film experiments were carried out in the non-clinical mode at the helical
tomotherapy unit.

An electronic communication was established between the

tomotherapy machine and the motion phantom through a cable, such that the film insert
motion would commence once the gantry angle reached zero. The initial phase of the
film insert motion was set at zero for all non-IMRT and IMRT cases by positioning the
film insert in its mid-position before the start of each radiation delivery.

2.2.3.4

Uncertainty Analysis

Five repeated “no motion” measurements for the non-IMRT cases (p = 0.8, Tg = 16 s)
were used to calculate the dose uncertainty inside the PTV. The measured dose profiles
were realigned to ensure that the center of the PTV in each dose profile matched with
those from the other dose profiles. A standard deviation was calculated for each dose
point, and then the mean of all the standard deviations values were determined to
represent the dose uncertainty of the film experiment in this study.
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2.3 Results and Discussion
2.3.1
2.3.1.1

Non-IMRT Helical Tomotherapy Cases
Dose Rounding Effect

In Figure 2.5 a), dose rounding effect 6 was illustrated in the measured coronal dose
distribution of a non-IMRT helical tomotherapy delivery. In the “no motion” dose
distribution (i), thread artifact7 was manifested as a series of dose ripples near the outer
edges of the dose distribution along the longitudinal direction (y). In the “motion” dose
distribution (ii), the dose rounding effect due to the longitudinal target motion led to the
“blurring” of a thread artifact, reducing the magnitude of off-axis dose ripples. The
presence of dose rounding effect was illustrated in the dose difference map (iii) between
the two dose distributions (“motion” dose distribution (i) – “no motion” dose distribution
(ii)). Underdosing was observed near the longitudinal PTV boundaries, while the regions
both superior and inferior to these boundaries experienced overdosing. Dose profiles
along the axis of gantry rotation (dotted line, x = 0 cm) were generated from the dose
distributions (i) and (ii) to further characterize the dose rounding effect.
As shown in Figure 2.5 b), the measured and simulated dose profiles both exhibited dose
rounding near the PTV boundaries due to the large peak-to-peak amplitude of target
motion (2A = 2.0 cm). The dose rounding effect resulted in the underdosing of the PTV
near its boundaries, and overdosing of the surrounding normal structures just outside the
PTV boundaries. As shown in Figure 2.5 b), dose rippling was absent due to the
synchronous interplay condition (β = integer = 5) between the couch motion and
longitudinal target motion. The dose rippling-like feature present inside the PTV region
for the measured “no motion” dose profile was attributed to the oval shape of the body
phantom (width = 30 cm, height = 20 cm), which yielded a different attenuation path
length as a function of gantry angle. A difference of 2.5 % was observed between the

6

Dose rounding is manifested as dose blurring in the direction of tumour motion, occurring near the
longitudinal boundaries of the target volume
7

Thread effect is an off-axis beam junctioning effect inherent to helical tomotherapy, which arises mainly
due to beam divergence. Please refer to Section 3.3.1, 5.2.2.1, 5.3.2, and 5.4.3 for further explanations.
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maximum and minimum dose values of this dose rippling-like feature for the “no
motion” dose profile, while the difference was reduced to 1.5 % for the “motion” dose
profile. The decrease in the dose difference was attributed to the “blurring” effect,
caused by the target motion along the longitudinal direction. The measured dose profile
exhibited a dose uncertainty of +0.5 %, calculated as the mean of standard deviations of
the dose values from the five re-aligned “no motion” profiles acquired under the same
delivery conditions. The simulated dose profile agreed with the measured dose profile
within a standard deviation of 0.5 % inside the PTV region.
The magnitude of dose rounding was quantified by the penumbral size, which was
calculated as the average of the distance between the 20 % and 80 % dose points (P20/80)
and the distance between the 80 % and 20 % dose points (P80/20). The simulated data
were generated for the different amplitudes of target motion, while using the same
treatment parameters and target motion period (Tr). The plotted data in Figure 2.5 c)
showed that the penumbral widening worsened with increasing amplitude (A) of target
motion. At the target motion amplitude of 1.0 cm, the penumbra size started to increase
linearly with the target motion amplitude for both target motion periods. The smaller
penumbral size was observed for the target motion period of 8 s (Tr = 8 s), as the
presence of dose ripples inside the PTV (Figure 2.6 b) led to the sharpening of the
penumbra.8 All the experimental data points agreed with the simulated data points within
1 mm.

8

Dose rippling (Section 2.3.1.2) inside the target is manifested as dose undulations along the dose ramp-up
and ramp-down regions, which may increase or decrease the penumbral size, depending on the phase of
tumour motion. In the absence of dose rippling, however, longer tumour motion period (Tr) will always
lead to an increase in penumbral size.
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Figure 2.5: (a) Measured film dose distributions on the central coronal plane for a
non-IMRT helical tomotherapy (p = 8, Tg = 16 s, R = 4) of a central target: in the (i)
absence and (ii) presence of target motion (Tr = 4 s, A = 1.0 cm, β = 5). (i) “no
motion” dose distribution, (ii) “motion” dose distribution (Tr = 4 s, A = 1.0 cm, β =
5), and (iii) dose difference map between (i) and (ii). The dotted lines represent the
axis of gantry rotation (x = 0 cm). (b) Normalized longitudinal dose profiles along
the axis of gantry rotation for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R
= 4) of a central target (Tr = 4 s, A = 1.0 cm). P20/80 is the distance between the 20 %
and 80 % dose points, used to quantify penumbral size. (c) Penumbral size vs.
amplitude of target motion for two different target motion periods (Tr = 4 s and 8 s)
for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target.
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2.3.1.2

Dose Rippling Effect

In Figure 2.6 a), dose rippling effect was illustrated in the measured coronal dose
distribution of a non-IMRT helical tomotherapy delivery.

In the “motion” dose

distribution (ii), the asynchronous interplay condition generated between the couch
motion and target motion yielded a dose rippling pattern inside the PTV along the
longitudinal direction (y). The thread artifact present in the “no motion” dose distribution
(i) was effectively absent in the “motion” dose distribution, as the larger peak-to-peak
motion (2A) of 3.0 cm compared to the peak-to-peak motion of 2.0 cm in Figure 2.5 a),
leads to an increased “blurring” of dose ripples, and the resulting absence of thread
artifact. In the dose difference map (iii), the presence of both dose rippling and dose
rounding effects are apparent. Dose profiles along the axis of gantry rotation (dotted line,
x = 0 cm) were generated from the dose distributions (i) and (ii) to further study dose
rippling effect.
As shown in Figure 2.6 b), both dose rounding and dose rippling were observed for the
measured and simulated dose profiles. Significant dose rounding occurred due to the
very large peak-to-peak amplitude of target motion (2A = 3.0 cm). The asynchronous
interplay condition (β ≠ integer = 2.5) produced a dose rippling pattern with the dose
variation of 3.0 %. The dose variation was measured as the difference between the
lowest dose valley and the highest dose peak found inside the PTV region. The simulated
dose profile agreed with the measured dose profile within a standard deviation of 0.5 %
inside the PTV region.
As shown in Figure 2.6 c), the dose profiles were generated by the simulation program
for different combinations of pitch factor (p) and gantry rotation period (Tg), while
keeping the β value at 2.5. The target motion period (Tr) was fixed at 8 s. The
magnitude of dose ripples remained at ~2.5 % for all cases, demonstrating that the dose
rippling effect is independent of the individual parameters governing the β value.9 The

9

Although the effect of varying the tumour motion period was not presented here, the magnitude of dose
ripples remains comparable for the same β value acquired with different Tr values.
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effect of target motion amplitude (A) on the magnitude of dose ripples was also
investigated using the simulation results. In Figure 2.6 d), the dose variations are plotted
as a function of target motion amplitude for a fixed β value of 2.5. The dose variation
plot exhibits a sinusoidal-like pattern with the peak of each cycle decreasing with the
target motion amplitude. This particular pattern is rather non-intuitive as the largest dose
variation of 8 % is observed at a relatively small target motion amplitude of 0.30 cm.
In the initial rise (0 < A < 0.3 cm), the dose variation increases with the target motion
amplitude (A), due to the respective increase and decrease of the maximum and minimum
dose inside the PTV. The maximum dose is received by the PTV points that move into
the beam both at the start and end of their irradiations, thus increasing the overall
exposure time compared to the static case. On the other hand, the minimum dose points
recede away from the beam at the start and move past the beam near the end of their
irradiations, resulting in the decrease of the overall radiation exposure time. When the
target motion increases beyond A = 0.3 cm, the maximum dose points start to spend time
outside the beam during their irradiations, with the duration of time outside the beam
increasing with the target motion amplitude. The decrease in the maximum dose is then
compensated by the minimum dose points spending additional time inside the beam. As
a result, the dose variation starts to decrease with the amplitude of target motion (0.3 < A
< 0.6 cm).
The respective decrease and increase of the maximum and minimum dose continue, until
the dose received by the “old” minimum dose points surpasses the dose received the
“old” maximum dose points, thus leading to switches between the positions of the
maximum and minimum dose points. The same trend previously observed in the initial
rise (0 < A < 0.3 cm) is then repeated for 0.6 < A < 0.85 cm, explaining the periodic
nature of the dose variation pattern. The dose variation peaks at the different amplitudes
(A = 0.3, 0.85, 1.35, and 1.85 cm) decrease with the amplitude of target motion, as the
maximum dose points move out of the beam more frequently during their irradiations
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with increasing target motion amplitude, thus reducing the maximum exposure time and
the corresponding dose variation.10
In Figure 2.6 e), the dose rippling magnitude was plotted as a function of dose rippling
parameter (β) for the different target motion amplitudes, exhibiting patterns similar to
“sinc” functions. “Nodes” were observed at all the integer β values, as dose rippling
becomes absent at these values.

The dose rippling magnitude does not change

monotonically with the target motion amplitude, but rather changes up and down in a
sinusoidal-like manner related to the pattern illustrated in Figure 2.6 d). The dose
rippling magnitude declined rapidly with increasing value of dose rippling parameter (β),
approaching less than 1 % at the β value of 4.5 for all the target motion amplitudes.11
The largest dose rippling magnitude of ~25 % was observed for the target motion
amplitude of 0.5 cm and the β value of 1.5, where the target motion period (Tr)
approached an unusually high value of 10 s. Dose rippling parameter values lower than
one (β < 1) were not applicable to helical tomotherapy, and thus were not investigated in
this study. For the sliding window technique, however, higher velocities of the jaw
motion (compared to the couch motion) lead to faster radiation beam movements than
helical tomotherapy, which in turn yield lower the dose rippling parameter values. In the
study by Yu et al [18], the employed jaw motion velocities produced β values ranging
from 0.035 to 1. The dose rippling magnitude approached as high as 400 % for β values
close to 0.1.

10

The maximum dose points moving out of the beam more frequently simultaneously translates into the
minimum dose points moving into the beam more frequently, overall reducing the dose variation.
A non-integer β value indicates the presence of an incomplete tumour motion cycle during the time for
the treatment couch to advance by one fan beam thickness (Tg / p). The incomplete portion of a tumour
cycle leads to the different points within the target to experience different radiation exposure time. With
increasing β value, the absolute time of this incomplete portion decreases, thus reducing the variation in
radiation exposure time between different points, which in turn leads to a reduction in dose rippling
magnitude.
11
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Figure 2.6: (a) Measured film dose distributions on the central coronal plane for a
non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target: (i) “no
motion” dose distribution, (ii) “motion” dose distribution (Tr = 8 s, A = 1.5 cm, β =
2.5), and (iii) dose difference map between (i) and (ii). The dotted lines represent the
axis of gantry rotation (x = 0 cm). (b) Normalized longitudinal dose profiles along
the axis of gantry rotation for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R
= 4) of a central target (Tr = 8 s, A = 1.5 cm, β = 2.5). The dose variation was
measured as the difference between the lowest dose valley and the highest dose peak
found inside the PTV region. (c) Simulated longitudinal dose profiles along the axis
of gantry rotation for a non-IMRT helical tomotherapy of a central target (Tr = 8 s,
A = 1.5 cm, β = 2.5). Four different dose profiles were generated using different
combinations of pitch factor (p) and gantry rotation period (Tg), while keeping the β
value at 2.5. (d) Simulation study: Dose variation vs. target motion amplitude (Tr =
8 s) for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target
under the asynchronous interplay condition (β ≠ integer = 2.5). (e) Simulation
study: Dose rippling magnitude vs. dose rippling parameter (β ) for different
amplitudes of target motion for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s,
R = 4) of a central target.
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2.3.2

IMRT Helical Tomotherapy Case

As shown In Figure 2.7 a), simulated longitudinal dose profiles were generated for the
different values of target motion periods for an IMRT helical tomotherapy delivery. The
unusually large target motion period of 15 s yielded a dose rippling pattern inside the
PTV with a magnitude of 2.0 % (β ~ 3.5). Meanwhile, the dose profile resulting from the
target motion period of 4 s showed little differences from the “no motion” dose profile.
While no major dose discrepancies were observed for Tr = 15 s and 4 s, one couldn’t
interpolate or predict the major dose perturbations at Tr = 8 s , based on the results from
the other target motion periods. The IMRT leaf opening synchronization effect was
observed, producing the largest dose discrepancies of 11.3 %12 for the motion amplitude
of 0.3 cm. Further investigations with other target motion periods (not presented here)
showed that the IMRT leaf opening asynchronization effect was plan-specific. The
artifact was present at a wider range of tumour motion periods than the dose rippling
effect, with the largest dose discrepancies observed at a particular target motion period, 8
s for the particular IMRT helical tomotherapy case investigated in this study.
In Figure 2.7 b), the effect of target motion is illustrated in the coronal dose distribution
of an IMRT helical tomotherapy delivery for a target motion period of 8 s. The dose
difference map (iii) between the planned (“no motion”) and delivered (“motion”) dose
distributions demonstrated significant motion-induced dose errors. The longitudinal dose
profiles were then obtained along the axis of gantry rotation for the “no motion” and
“motion” dose distributions to further examine the different dose discrepancies present.
In Figure 2.7 c), the measured and simulated dose profiles exhibited IMRT leaf opening
asynchronization effect and dose rounding effect.

The IMRT leaf opening

asynchronization effect was observed inside the PTV region, where the difference
between the measured “motion” and “no motion” dose profiles ranged from -29 % to 7
%. The asynchronous interplay between the temporal patterns of leaf openings and target

12

The dose discrepancy of 11.3% was calculated as the total variation in dose differences between the
planned and delivered dose profiles inside the target, which ranged from -6.1 to 5.2% for tumour motion
period (Tr) of 8 s.
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motion is the cause of this effect. The simulated dose profile agreed with the measured
dose profile within a standard deviation of 1.7 % inside the PTV region.
Significant dose rounding was also observed near the PTV boundaries due to the very
large peak-to-peak amplitude of target motion (2A = 3.0 cm). However, dose rippling
was not observed despite the asynchronous interplay condition (β ≠ integer ~ 6.5), as the
use of a tighter pitch factor (p = 0.287) compared to the non-IMRT cases (p = 0.8)
yielded a much higher non-integer β value (β ~ 6.5 versus β = 2.5). It was previously
shown in Figure 2.6 c) that the dose rippling magnitude started to become insignificant at
β = 4.5 for all the target motion amplitudes, thus explaining the absence of dose rippling
at β ~ 6.5. Dose rippling was also not observed in the study by Kanagaki et al [20],
where a pitch factor of 0.3 was assigned for all the IMRT helical tomotherapy cases,
yielding high β values varying from 10 to ~67. Therefore, dose rippling should not be a
concern clinically, unless the breathing patterns exhibit unusually lengthy tumour motion
periods (Tr). In the clinical setting, pitch factors (p) of less than 0.3 are typically used
along with the gantry rotation periods (Tg) ranging from 15 to 20 s, likely driving the β
values well above 4.5.
The characteristics of the IMRT leaf opening asynchronization effect were further
investigated by studying its relationship with the target motion amplitude, and also the
effect of having multiple fractions. In Figure 2.7 d), underdosing of the PTV and dose
rounding both worsened with increase in the target motion amplitude, while the PTV
overdosing was significantly reduced for the amplitude of 2.0 cm. In Figure 2.7 e), the
effect of delivering multiple dose fractions on the IMRT leaf opening asynchronization
effect was investigated by introducing a random starting phase of target motion for each
fraction for the total of 30 fractions. The resulting dose profiles were then summed up to
generate a single composite profile. When compared to the “no motion” profile, the
“random phase” dose profile exhibited significant dose differences ranging from -16.5 %
to 1.5 %. The “random phase” dose profile was also quite symmetrical in shape. This
was attributed to the fact that most of the 30 randomly generated dose profiles had dose
profiles that were roughly mirror images of themselves. In Figure 2.7 e), the dose
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profiles with the starting phases of 00 and 1800 were essentially the mirror images of each
other.13

13

The dose profiles with the starting phases of 00 and 1800 were identical to their corresponding singlefraction dose profiles.
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Figure 2.7: (a) Simulated longitudinal dose profiles along the axis of gantry rotation
for an IMRT helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (A
= 0.3 cm) for different target motion periods (Tr). (b) Measured film dose
distributions on the central coronal plane for an IMRT helical tomotherapy (p =
0.287, Tg = 15 s) of an off-axis target: (i) “no motion” dose distribution, (ii) “motion”
dose distribution (Tr = 8 s, A = 1.5 cm), and (iii) dose difference map between (i) and
(ii). The dotted lines represent the axis of gantry rotation (x = 0 cm). (c)
Normalized longitudinal dose profiles along the axis of gantry rotation for an IMRT
helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (Tr = 8 s, A = 1.5
cm). (d) Simulated longitudinal dose profiles along the axis of gantry rotation for an
IMRT helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (Tr = 8 s)
for different target motion amplitudes (A). (e) Simulated longitudinal dose profiles
along the axis of gantry rotation for an IMRT helical tomotherapy (p = 0.287, Tg =
15 s, R = 8) of an off-axis target (Tr = 8 s, A = 1.5 cm) for 30 fractions.
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2.3.3

Potential Solutions for Minimization of the Three Dose
Discrepancies

Various approaches have been proposed to minimize the effect of tumour motion during
helical tomotherapy [4,11-13]. Increasing the PTV margin size along the direction of
target motion is the simplest way to compensate for the dose rounding effect, at the
expense of increasing the integral dose to the patient. In Figure 2.5 c), the penumbral
widening due to dose rounding was shown to be proportional to the target motion
amplitude (A), thus making the PTV margin size directly dependent upon the target
motion amplitude. However, the dose rippling and IMRT leaf opening asynchronization
effects cannot be resolved by this approach alone, as the asynchronous interplay
conditions still remain.

The effects of all three dose artifacts could be minimized

effectively by immobilizing the target volume only during the “beam ON” time through
breath-holding [11,13]. However, breath-holding may not be feasible physically for all
lung cancer patients, due to their compromised lung functions.

In the “motion-

incorporated helical tomotherapy”, the tumour motion information acquired prior to the
treatment is utilized during the plan optimization process [12,26]. As a result, the tumour
motion is accounted for during the treatment, while the patient is still allowed to breathe
normally. This method, however, requires the patient to reproduce the identical breathing
pattern used for planning during the treatment, which may not be guaranteed in practice.
Failure to reproduce the same breathing pattern can result in significant dose
discrepancies between the planned and delivered dose distributions.
Respiratory gating can be incorporated into helical tomotherapy in the form of the “multipass respiratory gating technique” [27], without placing any constraints on the patient
breathing. Due to the continuous motion of the treatment couch, multiple passes of
helical tomotherapy deliveries are required to complete the helical tomotherapy plan,
instead of the conventional single pass. During each pass, only the beam projections
overlapping with the gating windows are delivered, while the remaining beam projections
are “blocked” by the complete closure of all 64 binary MLC leaves. After each pass, the
couch is reset to its starting position, and the treatment commences at a different phase of
tumor motion for the gating windows to cover the previously undelivered beam
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projections.

This process is repeated until all of the planned beam projections are

delivered. Respiratory gating reduces the magnitude of target travel during the “beam
ON” time, leading to the decrease in both the penumbral size and the PTV margin size
required to compensate for dose rounding. Respiratory gating also alters the periodicity
of the target motion during the “beam ON” time. Thus, the asynchronous conditions
existing for the dose rippling and IMRT leaf opening asynchronization effects can be
altered into the synchronous conditions, resulting in the minimization of both effects.
The disadvantages of respiratory gating include the escalations in the treatment time and
the patient integral dose, resulting from the multiple passes. The feasibility of this
approach continues to be investigated in our laboratory.

In the “real-time motion-

adaptive delivery” [4], the beam projections of a planned leaf opening sinogram are
delivered out of order (“shuffled”) according to the tumour motion, rather than
sequentially. This means that in place of each planned beam projection, a past or future
beam projection corresponding to the position of the tumour volume at a given time is
selected and delivered. This particular method also places no constraints on the patient
breathing. Each of the proposed techniques relies on various assumptions about the
nature of tumour motion, and offers advantages and disadvantages for the helical
tomotherapy treatment of a moving target.

2.4 Conclusions
In this study, three different dose discrepancies arising from the presence longitudinal
tumour motion during helical tomotherapy were identified. Their characteristics were
investigated through both computer simulation modeling and experimental verification
using a motion phantom with film. The characteristics of the three different motioninduced dose discrepancies were illustrated, and the dosimetric significance of each effect
was described. The computer simulation model was shown to be a valuable tool for
predicting the dosimetric impact of target motion during helical tomotherapy, as the
calculated dose profiles agreed with the measured data within +0.5 % and +1.5 % inside
the PTV region for the non-IMRT and IMRT tomotherapy deliveries, respectively.
Various potential solutions to minimize the effect of target motion were also discussed,
and each proposed method needs to be investigated for its effectiveness in suppressing
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the three dose discrepancies described here. The computer simulation model could also
prove useful during the patient selection process for the different approaches of
minimizing dose artifacts.
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Chapter 3

3

Investigation of Dose Homogeneity for Loose Helical
Tomotherapy Delivery in the Context of Breath-Hold
Radiation Therapy

The work in this chapter is based on a publication, “Kim B, Kron T, Battista J, and Van
Dyk J (2005) Investigation of dose homogeneity for loose helical tomotherapy delivery in
the context of breath-hold radiation therapy. Phys Med Biol 50, 2387-404.”
http://dx.doi.org/10.1088/0031-9155/50/10/014

3.1 Introduction
3.1.1

Helical Tomotherapy

In helical tomotherapy (HT) [1,2], an intensity-modulated fan beam of radiation is
delivered to the patient in a helical manner, as a result of gantry rotation occurring
simultaneously with linear couch motion (Figure 3.1). Each gantry rotation is divided
into 51 equally-spaced beam projections with each projection spanning over ~7°. Beam
modulation is facilitated by a binary multi-leaf collimator (b-MLC) consisting of 64
leaves. Overall, these features provide tomotherapy with the ability to sculpt a highly
conformal dose distribution. The gantry rotation period (Tg) can be set between 10 s and
60 s, depending on the dose that needs to be delivered per rotation. In the standard
tomotherapy practice, the couch advances by less than the fan beam thickness during
each gantry rotation (i.e. pitch factor < 1), in order to avoid problems of abutment regions
which may occur in serial tomotherapy [3]. Pitch factor (p) is defined as the amount of
couch translation that occurs during one gantry rotation, divided by the fan beam
thickness (b). Fan beam thickness (b) is the defined as the distance between the 50% of
the maximum dose value along the axis of gantry rotation in the direction of couch
translation. Other tomotherapy parameters include the number of beam projections per
gantry rotation (n), and number of gantry rotations (R) required to cover the entire target
length along the direction of couch motion.

74

Figure 3.1: Helical tomotherapy (HT): The helical line depicts the path of beam
projections (stars) during a tomotherapy treatment. The Y-axis indicates the
direction of couch motion. HT-specific parameters include fan beam thickness (b),
number of beam projections per gantry rotation (n), and number of gantry
rotations (R) required to cover the entire target. The distance travelled during one
gantry rotation is determined as the product of fan beam thickness and pitch factor
(b x p).

3.1.2

Target Motion

Respiration-driven target motion is a major problem in radiation therapy of lower lobe
lung cancer, as larger target margins are required to compensate for the target’s range of
motion, which may reach up to several cm’s [4-6]. As a result, a significant volume of
healthy lung tissues is exposed to radiation, which in turn limits the maximum dose that
can be delivered to the tumour. Thus, it is crucial to address target motion in order to
take full advantage of highly conformal dose delivery provided by HT. Four motion
mitigation methods are currently available for conventional radiation therapy and IMRT
(Table 3.1). Of these choices, breath-holding appears to be the easiest one to implement
for HT. Other techniques would require a complex control mechanism to co-ordinate the
movement of the three HT subsystems (gantry, b-MLC, and couch) with respect to the
target motion. In contrast, breath-holding requires no such effort as the target motion is
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significantly reduced within the treatment field during radiation delivery. Breath-holding
also allows one to choose the phase within the breathing cycle, which is most ideal for an
effective treatment. Thus, we propose a different HT approach, namely loose helical
delivery, which is ideally suited for breath-hold HT. Although loose helical delivery has
been suggested [15], it has never been fully studied or described in the literature. In the
present study, the dosimetric characteristics of loose helical delivery are investigated in
comparison to standard HT. Standard HT (p < 1) is referred to as tight helical delivery
throughout this paper. Different HT cases have been simulated in the treatment planning
software and then verified experimentally with film.
Table 3.1: Motion mitigation methods.

3.1.3

Loose Helical Delivery

Loose helical delivery consists of a number (H) of individual interlaced “loose” helices
commencing at different gantry angles. The starting gantry angles are equally divided
around the gantry, while the same starting couch position is assigned to all loose helices
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(Figure 3.2). Each loose helix covers the entire target length in a single gantry rotation (R
= 1) by utilizing a pitch factor of greater than 1 (p > 1), during which breathing-holding
takes place. This way no interruptions are required during beam delivery except for cases
such as coughing where the target accidentally moves out of the treatment field.

The

gantry rotation period (Tg) should be set to the minimum allowed time of 10 s in order to
maximize the number of patients who can tolerate this approach. After the completion of
each loose helix, the couch travels back to its starting position for the next loose helix to
begin. It is during the time slots between the helices when the patient is allowed to
breathe normally. The required pitch factor for loose helical delivery is calculated by
Equation 3.2, which is derived from Equation 3.1. It is directly dependent on the length
of target (L) along the axis of gantry rotation and the fan beam thickness (b):
R = # of rotations needed =

target length + fan beam thickness L + b
=
fan beam thickness × pitch factor
b⋅ p

(3.1)

Therefore, for loose helical delivery :
R =1=

L+b
⇒
b⋅ p

p=

L+b
b

(3.2)

Figure 3.2: Loose helical delivery: each loose helix (p > 1) with a different starting
gantry angle covers the entire target in one gantry rotation (R = 1), during which
breath-holding takes place. Required pitch factor is dependent on target length and
fan beam thickness. In this example, loose helical delivery consists of four helices (H
= 4).
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3.2 Materials and Methods
HT treatments were simulated in the conventional linear accelerator environment, since
the current HT planning software does not allow for the optimization of loose helical
delivery. The HT beam was represented by the 6 MV x-ray beam from a conventional
linear accelerator (Varian Clinac 2100 C/D) collimated to a fan beam geometry. The
normalized photon spectrum of a HT beam is comparable to that of the 6MV Varian
Clinac beam with the similar maximum photon energy of 6 MV, although the peak of the
energy spectrum shifts from 0.4 MeV to 0.5 MeV for the HT beam [16]. The absence of
the flattening filter and the shorter source-to-axis distance (85 cm versus 100 cm) of the
HT machine (TomoTherapy Inc., Madison, WI) were not modelled in this study. As a
result, the 6MV beam used in this study has a slightly different TPR 20/1014 value of 0.67
compared to the TPR 20/10 value of 0.63 for the HT beam.
During a HT delivery, each gantry rotation is equally divided into 51 beam projections by
momentary closing of all leaves between the beam projections.

Radiation delivery

remains continuous over the span of each beam projection. In study, however, the
individual beam projections were depicted as “snap-shots” of radiation occurring at
different gantry angles. Each beam projection was modelled as an open beam with no
beam intensity modulation. In order to mimic the continuous couch motion of a HT
machine, each beam projection was assigned a unique couch position. The displacement
between beam projections, termed here as “projection increment” was calculated as
follows:
projection increment =

couch translation per gantry rotation
p ⋅b
=
# of beam projections per gantry rotation
n

(3.3)

In the present study, both loose and tight helical deliveries with limited numbers of beam
projections (i.e. less than 51) were chosen to investigate the dosimetric impact of the
tomotherapy parameters. The different HT cases studied are summarized in Table 3.2. A

14

Tissue-phantom ratio (TPR) is the ratio of the dose at a given point in phantom to the dose at the same
point at a reference depth for the same field size. TPR 20/10 is the TPR ratio at depths of 20 cm and 10 cm
in water.
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fan beam thickness of 4.5 cm (Y) and a fan beam width of 10 cm (X) were selected to
treat an arbitrary cylindrical target (10 cm in diameter, 4.5 cm (Y) in length) inside a
cylindrical phantom with a diameter of 20 cm (Lucite, ρ = 1.18 g/cm3). Central axes of
both the target and the phantom were aligned to the axis of gantry rotation of the linear
accelerator.
Table 3.2: Tomotherapy scenarios.15

3.2.1

Computer Simulations

The HT cases summarized in Table 3.2 were planned with Theraplan Plus (TPP) v.3.0
software (MDS Nordion, Kanata, Canada). The treatment planning software uses a
pencil-beam algorithm, and the equivalent tissue-air ratio (TAR) method [17] including
electron transport [18] for inhomogeneity corrections when using photon beams. The 6
MV photon beam model was specifically commissioned for the fan beam dimension (10
cm (X) x 4.5 cm (Y)) based on film data.16 Film data were obtained for three different

15

For loose helical delivery, number of loose helices was selected such that the total number of beam
projections remains the same as tight helical delivery.
16

Film data were acquired to provide depth dose profile information for different field size.
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square field sizes (4.5 cm, 6.2 cm, and 10 cm) at five different depths (0.5 cm, 1.5 cm, 3
cm, 5 cm and 10 cm), as TPP only allows square field data for beam modelling [19].
Instead of using the CT images of the actual phantom where a slice spacing (Y) of 3 mm
would be used, a virtual phantom was created within TPP to produce a finer slice spacing
of 1 mm (Y), thus allowing dose calculation at that interval. A relative electron density
of 1.146 [20] was assigned to the whole phantom to represent Lucite (ρ = 1.18 g cm-3).
All dose calculations were performed using a pencil beam size of 1 mm with
inhomogeneity corrections. The dose calculation grid spacing of 1 mm was used along
all axes (X, Y, Z). Dose profiles were obtained along X = 0 cm, +2 cm, +4 cm axes on
the calculated dose distribution plane (Z = 0 cm) bisecting the target.
The calculated dose distributions were normalized to the sum of beam weights, each of
which represented the dose at the isocentre.

Percentage dose values were then re-

normalized to the average dose along the central section (3.9 cm) along the axis of gantry
rotation. The length of 3.9 cm was determined by subtracting 3 mm from each side of the
target length (4.5 cm) to account for the rounding of dose profile.

3.2.2

Experimental Verification

Experiments were carried out on the linear accelerator to verify the dose distributions
calculated by Theraplan Plus. Each experiment was performed with a film placed inside
the cylindrical phantom (Lucite, ρ = 1.18 g/cm3, 20 cm in diameter and length), which is
shown in Figure 3.3. Kodak EDR2 film was chosen for the relatively large linear dose
response range of 25-400 cGy [21-24]. A 10” x 12” film was cut in half and placed
inside the film cassette of the phantom. The film cassette is made of black-coloured
Lucite (ρ = 1.18 g/cm3) in order to prevent light from reaching the film. Inside the film
cassette, two film pieces are separated by a 6 mm film divider to provide dose
distribution results for two planes (Z = 0 cm and Z = -0.6 cm). However, only the
outcomes for Z = 0 cm plane are presented in this study. Three trials were performed for
Case 1 of loose helical delivery (n = 5) to determine the reproducibility of the
experiment.
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Figure 3.3: Cylindrical Lucite (ρ = 1.18 g cm-3) phantom

The number of monitor units (MU) delivered per beam projection is calculated so that the
total number of monitor units remains approximately the same for all cases:
n × R × MU ≈ constant

After each beam projection, the couch was unlocked and manually translated to the next
couch position, according to the projection increment calculated using Equation 3.3.
Rulers taped on both sides of the phantom were used to verify the position of the
phantom with the cross-sectional laser. Each film was scanned and analyzed using film
dosimetry system software (RIT 113 v.3.13). Dose profiles were obtained along X = 0
cm, +2 cm, +4 cm axes on the Z = 0 cm coronal plane. A calibration film was taken on
each experimental day using an open 6 MV photon beam. A calibration film was taken
on each experimental day using an open 6 MV photon beam. The calibration film was
exposed at the isocentre with four 4 x 4 cm2 fields with different monitor units (25 MU,
100 MU, 175 MU, 250 MU) with a 5 cm buildup of solid water.

3.3 Results
Both computer simulations and film experiments were used to study the dose
homogeneity for loose helical delivery compared to standard HT in a cylindrical target.
Two major effects were observed: the “thread” effect and the “beating” effect. In this
section, results defining and characterizing these two effects are presented.
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3.3.1

“Thread” Effect

In Figure 3.4, the dose distribution results based on the TPP and the film data are
presented for the two delivery methods: tight (Case 2, n = 5) and loose helical delivery
(Case 3, n = 10). The dose patterns observed in the TPP data are supported by the film
data. In Figure 3.4 a) and c), the dose distribution for Case 2 (n = 5) of tight helical
delivery is characterized by the presence of higher dose regions, occurring away from the
axis of gantry rotation – known as the “thread” effect [25]. The higher dose regions
consisted of dose values greater than 100 % and in this case, the maximum dose value
reached ~105 %. The positions of these higher dose regions followed a helical path with
respect to the axis of gantry rotation. This particular dose pattern due to the thread effect
was observed in all tight helical delivery cases in this study. The thread effect was also
manifested as ripples in the isodose plots of HT plans produced for complex lung cases at
our institution [26], confirming that the thread effect is indeed an inherent characteristic
of HT.
The presence of higher dose regions led to dose modulations in the off-axes dose profiles
(X = + 2 cm, + 4 cm). Dose modulation is defined as the peak-to-trough difference in
percent dose within the target region, while off-axes include all longitudinal axes parallel
to the axis of gantry rotation, except the axis of gantry rotation. It was observed the
magnitude of dose modulations increased away from the axis of gantry rotation, while no
dose modulations were observed along the axis of gantry rotation (X = 0 cm) for all tight
helical delivery cases.

82

Figure 3.4: Dose distribution results on the coronal plane Z = 0 cm for: (a) Case 2 (n
= 5) of tight helical delivery (p = 0.5), Theraplan Plus (TPP). (b) Case 3 (n = 10) of
loose helical delivery (p = 2), Theraplan Plus (TPP). (c) Case 2 (n = 5) of tight
helical delivery (p = 0.5), film. (d) Case 3 (n = 10) of loose helical delivery (p = 2),
film. The dotted line in each dose distribution represents the axis of gantry rotation
(X = 0 cm). The solid arrows in (a) are pointed to the higher dose regions, which are
spaced by b x p (fan beam thickness times pitch factor). The white circular annulus
observed in (d) is an artifact due to the underlying mechanical couch structure.
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The thread effect and the absence of dose modulations along the axis of gantry rotation
are due to beam divergence. It causes the magnitude of fan beam thickness to vary away
from the axis of gantry rotation. Along the axis of gantry rotation, the fan beam thickness
(b) remains the same (i.e. 4.5 cm) at all gantry angles. However, at the off-axes, the
magnitude of fan beam thickness (b’) changes as a function of the off-axis position (X)
and the beam gantry angle (θ) according to:
 100 cm − X sin θ 
 SAD − X sin θ 
 4.5 cm
b' ( X , θ ) = 
 b = 
100 cm
SAD





(3.4)17

At the off-axes, beam projections with different fan beam thickness lead to peaks and
troughs in the primary fluence profiles. In Figure 3.5, the schematic illustration is
presented for the primary fluence profile along an off-axis, X = 4 cm for Case 2 (n = 5) of
tight helical delivery. Each beam projection is represented by a rectangle, whose width
and height represent fan beam thickness and primary photon fluence, respectively. The
main purpose of this schematic illustration was to show the variation in the intensity
pattern due to beam projection overlaps, as change in fluence according to the distance
from the source was not modeled.
The overall pattern of the fluence profile shown in Figure 3.5 supports the dose
modulation pattern observed in the dose profiles (Figure 3.6) obtained from the TPP and
the film data. The fluence profile consists of a set of two troughs and two peaks,
followed by another set, where each set contributes to a dose peak. The two sets of
troughs and peaks in the fluence profile are separated by the same distance as the two
dose peaks, which is the couch distance travelled during one gantry rotation (b x p).

17

sinθ = cos(900-θ)
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Figure 3.5: Schematic fluence profile along the X = 4 cm axis for Case 2 (n = 5) of
tight helical delivery (p = 0.5). The target (4.5 cm) is treated over 4 gantry rotations
(R = 4) with a fan beam thickness (b) of 4.5 cm. Each rotation is comprised of 5
beam projections with following gantry angles: 0°, 72°, 144°, 216°, 288°. The fan
beam thickness (b’) along the X = 4 cm axis changes as a function of gantry angle
according to Equation 3.4.

Figure 3.6: Dose profile along the X = 4 cm axis for Case 2 (n = 5) of the tight helical
delivery based on the Therplan Plus (TPP) data, and the film data.
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Along the axis of gantry rotation inside the cylindrical target, both the fan beam thickness
and the primary photon fluence remain the same at all gantry angles. These conditions
result in a primary fluence profile with homogenous fluence without any modulations
inside the target region (Figure 3.7). Homogenous fluence within the target profile in
turn produces dose profiles exhibiting no dose modulations (Figure 3.8). The absence of
dose modulations along the axis of gantry rotation was true for all tight helical delivery
cases.
In Figure 3.4 b) and d), higher dose regions are noticeably absent in the dose distribution
for Case 3 (n = 10) of loose helical delivery. In Figure 3.9, it is illustrated that along the
off-axis X = 4 cm, the change in fan beam thickness due to beam divergence is
counteracted by the presence of multiple beam gantry angles at each couch position. As a
result, the off-axes dose modulations inherent in tight helical delivery are eliminated
(Figure 3.10), and a more homogenous dose distribution is produced, illustrating the
dosimetric advantage of loose helical delivery.
In Figure 3.4, the five narrow strips18 observed near the boundaries of high dose region
(between X = +4 cm and +5 cm) resulted in the maximum dose modulation of 1% and
2% for TPP and film, respectively. The strips were separated by a distance equal to the
projection increment, which was 0.9 cm for this case.

This dosimetric feature is

attributed to the fact that each beam projection undergoes different amount of attenuation
before reaching a point along the off-axis. As a result, a different dose is deposited by
each beam projection. As the off-axis position moves away from the axis of gantry
rotation, the variation in the depth dose of the different beam projections becomes greater
– thus producing small dose variations observed near the boundaries of the high dose
region. The same feature was observed for Case 5 of loose helical delivery (n = 18).
However, due to the overlaps of the strips (0.5 cm apart), no discernable dose
modulations were observed from the TPP data, while only a maximum dose modulation
of 1% was observed from the film data.

18

The five narrow strips refer to the thin white strips observed near the edges of the high dose region in
Figure 3.4 (d) for loose helical delivery.
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Figure 3.7: Schematic fluence profile along the axis of gantry rotation (X = 0 cm) for
Case 2 (n = 5) of tight helical delivery (p = 0.5). The target (4.5 cm) is treated over 4
gantry rotations (R = 4) with a fan beam thickness (b) of 4.5 cm. Each rotation is
comprised of 5 beam projections with following gantry angles: 0°, 72°, 144°, 216°,
288°.

Figure 3.8: Dose profile along the X = 0 cm axis for Case 2 (n = 5) of the tight helical
delivery based on the Theraplan Plus (TPP) data, and the film data
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Figure 3.9: Schematic fluence profile along the X = 4 cm axis for Case 3 (n = 10) of
loose helical delivery (p = 2). The target (4.5 cm) is treated with 4 interlaced loose
helices (H = 4). Each helix is comprised of 10 beam projections (n = 10) with a
different starting gantry angle (0°, 90°, 180°, 270°). The off-axis position (X = 4 cm)
results in different fan beam thickness (b’) at each gantry angle. Fluence variations
due to inverse square law and beam attenuation were not modelled.
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Figure 3.10: Dose profile along the X = 4 cm axis for Case 3 (n = 10) of loose helical
delivery based on the Theraplan Plus (TPP) data, and the film data

3.3.2

“Beating” Effect

The dose homogeneity within a dose distribution by loose helical delivery was affected
however, when the ratio between the number of beam projections (n) and pitch factor (p)
was not an integer. A non-integer n / p value produced unwanted dose modulations along
all off-axes as well as on the axis of gantry rotation, resulting in the “beating” effect
(Figure 3.11). The separation between dose peaks was equal to the projection increment.
As seen in Figure 3.11 and Table 3.3 (loose helical delivery case), increasing the n / p
ratio reduced the magnitude of dose modulations.
The maximum dose modulations for all tight and loose helical deliveries are summarized
in Table 3.3. An experimental uncertainty of 2 % (2σ) dose modulation was calculated
based on the relative standard deviation of the three trials performed for Case 1 of loose
helical delivery (n = 5). The dose modulations according to film data were consistently
higher than the TPP calculations, where an average difference of 3 % was found with 4 %
being the maximum. The difference was attributed to the fact that the treatment planning
software overestimates the tail regions of 6 MV beam profiles for different field sizes and
depths, thus yielding smaller dose modulations.
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Figure 3.11: Film results and dose profiles for loose helical delivery of (a) Case 1 (n
= 5), n / p = 2.5; (b) Case 4 (n = 15), n / p = 7.5. The dose profiles were taken along
the dotted line, representing the Y-axis axis.
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Table 3.3: Maximum dose modulations.

3.4 Discussion
3.4.1
3.4.1.1

Comparison of Loose and Tight Helical Delivery
“Thread” Effect

Tight helical delivery is characterized by the thread effect [25], which results in dose
modulations away from the axis of gantry rotation. In this study, the thread effect
produced dose modulations as high as 14 % inside the target region along the off-axes X
= +4 cm for n = 3 (Table 3 (tight helical delivery case). Dose modulations were present
even at n = 45 according to the TPP data, indicating that the thread effect takes place
regardless of the number of beam projections. Thus, dose modulations due to the thread
effect are expected to be present for the current HT unit (n = 51). This is indeed
confirmed by our experience with the unit and its treatment planning software [26].
The advantage of loose helical delivery lies in its ability to produce a homogeneous dose
distribution by eliminating thread effect. This was seen in Case 3 and 5 of loose helical
delivery, where the absence of higher dose regions resulted in dose profiles with no dose
modulations. This is due to the fact that loose helical delivery treats the target with
helices commencing at different gantry angles. We expect this advantage to persist also
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for intensity modulated HT deliveries as long as the different starting angles can be
included in the plan optimization.

3.4.1.2

Sensitivity to the Uncertainty of Couch Movement

The study by Yang et al [27] reported that the HT delivery is much less sensitive to the
uncertainty in couch position compared to serial tomotherapy [3]. A 1.0 mm error in
couch position resulted in 5% dose modulations, whereas in serial tomotherapy, dose
modulations could be as high as 20%. This is attributed to the difference in the dose
profiles (in the direction of couch motion) produced by the two techniques after each
gantry rotation. The resulting dose profile of the HT delivery after a single gantry
rotation is triangular in shape containing the “ramp-up” and “ramp-down” regions, in
contrast to the sharp drop-offs present in the dose profile of a serial tomotherapy beam.
As a result, the HT delivery can produce a uniform longitudinal dose distribution as long
as the dose profiles from the different gantry rotations are matched within a few mm,
while serial tomotherapy requires a more critical matching of the dose profiles.
For loose helical delivery, each loose helix produces a dose profile that is trapezoidal in
shape. There are no junction issues as in the tight helical delivery since the dose profiles
produced by the individual loose helices are being overlaid onto one another. At the
same time, loose helical delivery is more sensitive to systematic uncertainty compared to
the tight helical delivery, as the same starting couch position must be reproduced multiple
times. An uncertainty in the gantry repositioning is also introduced since loose helical
delivery requires different starting gantry angles for the individual helices. However, the
starting couch position is reproducible within an accuracy of 0.5 mm, and thus the impact
of the starting position uncertainty on the final dose distribution should be negligible.
The HT unit is capable of repositioning the gantry at the cardinal angles (00, 900, 1800
and 2700) within 10, and the uncertainty of this magnitude should have minimal effect on
the dose distribution. During a HT treatment, the couch position is accurate with +0.5
mm, and due to the higher couch velocity, loose helical delivery is less sensitive to the
impact of random uncertainty in the actual couch position compared to tight helical
delivery. Thus, overall loose helical delivery should be less sensitive to couch position
errors.
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3.4.1.3

“Beating” Effect and its Impact on Pitch Factor Selection

A non-integer n / p ratio results in the beating effect (first described in this work), which
creates dose modulations along all X-axes in the direction of couch motion inside the
target region. ICRU Reports 50 and 62 recommend the dose given to the planning target
volume (PTV) to be kept within +7% and -5% of the prescription dose, providing room
for 12% dose variation [28,29]. In clinical practice, it would be desirable to keep the
dose variation due to dose modulations under 5% in order to provide room for the other
sources of uncertainty. The film data suggest that the dose modulations will remain
under 5% when the n / p ratio is greater than 7.5.
With the number of beam projections fixed at 51 for the current tomotherapy unit, most
loose helical delivery cases will experience dose modulations, since pitch factors other
than 3 and 17 yield non-integer n / p ratios. As a result, a restriction must be imposed on
the maximum allowed pitch factor in order to keep the dose modulations below 5%. This
condition in turn places a limit on the maximum treatable target length, which depends
directly on the pitch factor (p) and the fan beam thickness (b) as shown in Equation 3.2.
Assuming that the findings in this paper are applicable to the current HT unit, the pitch
factor must be selected below 7 in order to keep the n / p ratio above 7.5 and the dose
modulations under 5%. This in turn limits the maximum treatable target length to 15 cm
and 30 cm, when using currently available fan beam thickness of 2.5 cm and 5 cm,
respectively (according to Equation 3.2).
In the future, improving the current MLC transit time (~30 ms) will increase the number
of beam projections deliverable per gantry rotation. As a result, the maximum treat target
length will become larger as well. If the option of adjusting the MLC transit speed ever
becomes available, one would be able to fix the rotation period to the breath-holding
capability of the patient and select the number of beam projections according to the target
length.
In a recent study, HT plans with two different planning target volumes were generated for
each of ten patients with stage 3 inoperable non-small cell lung cancer [30]. PTV2 was
created with a 2 cm margin around the gross tumour volume (GTV), while PTV1
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included regional lymph nodes in addition to the GTV. The cranial/caudal extensions of
these PTVs were 12.8 + 4.5 cm for PTV2 and 17.5 + 2.8 cm for PTV1. Considering the
ranges of target lengths for these two PTV volumes, loose helical delivery with a fan
beam thickness of 2.5 cm should be sufficient for most PTV cases containing the lung
tumour only, while a loose helical delivery plan including elective nodal treatment would
likely require a fan beam thickness of 5 cm.
The beating effect was not found to be an issue for the tight helical delivery cases in this
study, since their n / p ratios were all integers. Even if they were not integers, dose
modulations will always be smaller than 5% due to their large n / p values, except for
Case 1 where n / p is only 6. For the current tomotherapy unit (n = 51), the beating effect
will never be a concern for tight helical delivery (p < 1), since the n / p ratio will always
be larger than 51, which is significantly higher than 7.5.

3.4.2

Practical Considerations for the Use of Loose Helical
Delivery

The additional treatment time required for loose helical delivery arises from the sum of
couch re-set time between the helices. Thus, the increase in treatment time directly
dependent on the number of loose helices (H) used. Each re-set time is expected to last
for 30 s provide sufficient recovery time for the next breath-hold. The re-set time slots
are represented as the dark bands within the treatment time in Figure 3.12.
The number of loose helices (H) should be selected such that the total “beam-ON” time
(H x Tl) required to cover the target is comparable to the total “beam-ON” time (R x Tt)
for tight helical delivery. This ensures that the planned dose is delivered to the target
while performing an equivalent degree of beam intensity modulation. For loose helical
delivery, it can be assumed that the gantry rotation period will be set to the minimum
gantry rotation period of 10 s to account for compromised lung functions of patients.
Therefore, if the gantry rotation period in tight helical delivery is larger than 10 s, the
number of required helices (H) needs to be greater than the number of gantry rotations
(R) used in tight helical delivery. H is larger than R by the ratio of gantry rotation periods
used for the two deliveries:

94

H × Tl = R × Tt

⇒ H = R×

T
Tt
= R× t
Tl
10 s

(3.5)

where Tl is the gantry rotation period for loose helical delivery and Tt is the gantry
rotation period for tight helical delivery.
If one assumes a target length of 10 cm, tight helical delivery using a fan beam thickness
of 2.5 cm with the recommended pitch factor of 0.3 requires 17 gantry rotations to cover
a target of this magnitude. As a typical gantry rotation period ranges from 20 s to 30 s,
the treatment time should last anywhere from 5 to 10 minutes (Figure 3.12). In order to
achieve a similar beam-ON time with loose helical delivery, 34 to 51 loose helices are
needed. This yields a total couch re-set time of 15–25 minutes, increasing the total
treatment time to 20–35 minutes. However, the treatment time is only a portion of
session time as shown in Figure 3.12. Adding the time for set-up and MVCT (20
minutes) the total session time increases from 25–30 minutes to 40–55 minutes. This is
an increase by a factor of ~2, which may be acceptable given the dosimetric advantages
of loose helical delivery.

Figure 3.12: Total session time for: the tight helical delivery (top), loose helical
delivery (bottom). The dark bands within the treatment segment for loose helical
delivery represent couch re-set time between loose helices, during which the patient
breathes normally.
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The overall treatment time may be reduced by utilizing a fan beam thickness of 5 cm, as a
smaller number of helices will be required. Olivera et al [31] have shown that the use of
a larger fan beam thickness yields better dose uniformity. However, it also compromises
the ability to perform beam intensity modulation and the accuracy of dose conformation
to the target in the longitudinal direction. Therefore, using a fan beam thickness of 5 cm
would not reduce the number of helices by a factor of 2, but by a factor between 1 and 2.
At present, the HT treatment planning system does not allow for the planning of loose
helical delivery. However, if the loose helical delivery option ever becomes available,
the time and effort spent for planning and optimization remains the same, since the
overall number of projections stays the same as in tight helical delivery. Loose helical
delivery is also applicable to all tumour targets driven by respiratory motion. The tumour
sites may include liver and other sites within in the thoracic cavity.

3.4.3

Other Methods for Accounting for Respiration-Driven Motion
in HT

Table 3.1 gives a summary of all methods, which could be used for mitigation of motion
in radiation therapy. In the context of HT, both breath-holding and planning for motion
prospectively appear to be possible. In the present study, we have investigated loose
helical delivery as a potential means to combine breath-holding with improved dose
distributions. However, breath-holding may be incorporated into tight helical delivery as
well.

In the proposed “gating-by-rotation” approach, each rotation of breath-hold

treatment is followed by a rotation of non-treatment where the patient breathes freely [32].
During non-treatment rotations, the couch motion is halted and the treatment beam is
blocked by the closure of all MLC leaves. This on-off strategy is repeated for the full
treatment volume. The dose distribution outcomes of this approach essentially represents
those of tight helical delivery presented in this study, assuming breath-holding has been
carried out as planned.
Recently, the tomotherapy group in Madison, WI has proposed a method that
incorporates respiratory motion during the optimization process [13,14].

In this

approach, beamlet calculations are performed at the different phases of the CT data, once
the correlation between beam delivery and breathing is established.

The calculated
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beamlets are then mapped back to the primary phase according to the displacement maps,
and the plan optimization is carried out. The displacement maps are generated during
deformable image registrations of the lung at different phases. However, this method
only works under the condition that the patient’s breathing can correctly follow the
breathing guide on the given treatment day.

3.5 Conclusions


Loose helical delivery allows incorporation of breath-holding into helical
tomotherapy for a more effective treatment of respiration-driven tumour target.



The advantage of loose helical delivery lies in its ability to produce a
homogenous dose distribution by eliminating the “thread” effect – an inherent
characteristic of tight helical delivery.



Loose helical delivery, however, results in the “beating” effect, when the n / p
ratio is a non-integer. The magnitude of dose modulations due to the beating
effect decreases with an increasing n / p ratio. Thus, a pitch factor must be
selected such that the magnitude of dose modulations remains below 5 %.



The planning effort remains the same for loose helical delivery, and the total
treatment time increases only by a factor of 2, making loose helical delivery
clinically practical.



Overall, loose helical delivery is promising solution that should be strongly
considered for the future HT treatments of respiration-driven targets.
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Chapter 4

4

Feasibility Study of Multi-Pass Respiratory-Gated
Helical Tomotherapy of a Moving Target via binary MLC
Closure

The work in this chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista
J (2010) Feasibility study of multi-pass respiratory-gated helical tomotherapy of a
moving target via binary MLC closure. Phys Med Biol 55, 6673-94.”
http://dx.doi.org/10.1088/0031-9155/55/22/006

4.1 Introduction
Helical tomotherapy [1,2] utilizes a continuously rotating gantry and a linearly moving
couch to deliver an intensity-modulated fan beam of radiation in a helical manner.
Helical tomotherapy has been used extensively in the clinics, due to its IMRT dose
delivery capability combined with the on-line megavoltage CT available for image
guidance. Intensity modulation is performed by the binary multi-leaf collimator (bMLC), consisting of 64 interlaced binary leaves that either move into or out of the fan
beam field. The radiation fluence is then determined by the duration of leaf openings for
each of the 51 equally-spaced beam projections per gantry rotation. However, the fan
beam geometry and the movements of the three subsystems (gantry, couch, and
collimator) also make helical tomotherapy more susceptible to producing dose artifacts in
the presence of target motion [3-7].
Three major motion-induced dose discrepancies have been defined previously for helical
tomotherapy; (1) dose rounding, (2) dose rippling, and (3) IMRT leaf opening
asynchronization effect [7]. Dose rounding [3,6,7] is the penumbral widening of a
delivered dose distribution along the direction of tumour motion. Dose rippling [3-5,7] is
a series of periodic dose undulations inside the target volume along the direction of couch
motion, due to an asynchronous interplay between the couch motion and tumour motion.
The IMRT leaf opening asynchronization effect [7] is caused by an asynchronous
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interplay between the temporal leaf opening patterns of the b-MLC leaves and tumour
motion, yielding a dose discrepancy pattern unique to each tomotherapy plan.
In the past, various approaches have been proposed to compensate for tumour motion
during radiotherapy, in the form of breath-holding [8-10], respiratory gating [11-13], and
tumour-tracking [14,15].

Breath-holding may be incorporated to minimize tumour

motion during helical tomotherapy, although breath-holding may not be feasible for all
lung cancer patients due to their compromised lung functions [16,17]. Alternatively, the
tumour motion information acquired prior to the treatment may be included during the
plan optimization to allow normal breathing during the actual treatment [18,19].
However, this method assumes that patients can reproduce the breathing patterns used for
planning during treatments. Failure to reproduce the same breathing patterns can lead to
significant dose discrepancies. Real-time motion-adaptive delivery [20,21] was proposed
recently, where the sequence of planned beam projections is “shuffled” and executed outof-order according to the tumour motion, thus placing no constraints on patient breathing
patterns. The desired dose distributions, however, may not always be achieved, as this
method does not account for the radiological pathlength differences between the original
and shifted beam projections. The spatially shifted beam projections may encounter
different tissue thicknesses and densities, thus affecting the beam attenuation – especially
for large amplitudes of target motion.
We propose a new way to implement respiratory gating for helical tomotherapy, namely
multi-pass respiratory gating [22].

In this approach, the tumour motion during the

radiation delivery is restricted to the residual motion within the gating window. Thus,
this method reduces the beam attenuation differences caused by the relative motion
between the tumour volume and the surrounding normal tissues. Due to the continuous
couch motion during helical tomotherapy, the planned beam projections must be
delivered over multiples passes of radiation deliveries. The multiple passes may consist
of all gated passes (“full gating”) or multiple gated passes and one final ungated pass
(“partial gating”). In the present study, we investigated the feasibility and effectiveness
of the proposed technique for sinusoidal motion (“ideal” scenario) and a patient
respiratory motion pattern (“realistic” scenario). Full gating was tested for sinusoidal

102

motion, through experimental measurements with film and computer simulation for a
single fraction. For the patient waveform, both full and partial gating methods were
investigated for various fractionation schemes (1, 3 and 30 fractions), through computer
simulation.

The fractionation effect on the magnitude of dose discrepancies was

investigated, as the motion-induced dose deviations were previously shown to “smear
out” over multiple fractions of IMRT treatments [4,23,24]. It was assumed that each
treatment fraction commenced at a random phase of tumour motion. The interest for
hypofractionation (3 fractions) was prompted by the recent clinical trials on
hypofractionated stereotactic radiotherapy, which is current being regarded as a
promising treatment option for lung cancer [25-27].

4.2 Materials and Methods
4.2.1
4.2.1.1

Multi-Pass Respiratory Gating Technique
Helical Tomotherapy, Tumour Motion, and Gating
Parameters

The helical tomotherapy parameters include fan beam thickness (b), pitch factor (p),
gantry rotation period (Tg), leaf opening time per beam projection (Ta), and number of
gantry rotations per fraction (R). At the axis of gantry rotation (i.e. isocenter, SAD = 85
cm), the fan beam is projected to be 40 cm wide (X) with a selectable fan beam thickness
(b) of 1.05 cm, 2.5 cm, or 5.0 cm (Y). Pitch factor (p) is defined as the longitudinal (Y)
progression distance of the treatment couch per gantry rotation, in units of fan beam
thickness (b). Gantry rotation period (Tg) is the time required to complete one full gantry
rotation, which consists of 51 equally-spaced beam projections. During the different
beam projections, each binary leaf remains open for a planned duration (0 < Ta < Tg / 51).
In the current study, the gantry rotation periods of 15 s and 16 s were used for different
test cases. Gantry rotation periods of less than 20 s are typically used clinically for lung
tomotherapy. The total treatment time per fraction is thus the product of the gantry
rotation period (Tg) and the number of gantry rotations per fraction (R).
The tumour motion parameters consist of amplitude (A) and tumour motion period (Tr).
Amplitude (A) is defined as one-half of the peak-to-peak amplitude (2A) of tumour
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motion, while tumour motion period (Tr) is the time elapsed for one full cycle. In this
study, the effectiveness of the proposed technique was tested for the superior-inferior
motion only, as it is the predominant direction of tumour motion [24,28-30].
The gating parameters are number of passes (n), duty cycle (dc), and gating window size.
Duty cycle (dc) is a parameter used for phase gating, which is defined as the fraction of
tumour motion period (Tr) during which radiation is delivered. Gating window size is a
parameter for amplitude gating, which is the magnitude of target motion allowed during
gated radiation delivery.

4.2.1.2

Leaf Opening Sinogram

During a helical tomotherapy delivery, intensity modulation is performed by the b-MLC,
consisting of 64 interlaced binary leaves. The binary leaves travel along the longitudinal
direction (+Y) to either move into or out of the different sections of the fan beam. The
radiation fluence passing through the different beamlets is determined by the durations of
leaf openings during each beam projection. The leaf opening time information is stored
in the form of a leaf opening sinogram, which is a two-dimensional matrix of relative leaf
opening time values (T0), with the row and column indices representing leaf number and
beam projection number, respectively. The relative leaf opening time is defined as the
ratio of the actual leaf opening time (Ta) for a beam projection to the maximum leaf
opening time per beam projection (Tm = Tg / 51). In this study, a user-created leaf
opening sinogram was utilized for the non-IMRT cases, while a leaf opening sinogram
for the IMRT cases was generated via the helical tomotherapy plan optimizer
(TomoTherapy v. 2.2.2, TomoTherapy Inc., Madison, WI).

4.2.1.3

General Concept of Multi-Pass Respiratory Gating

In the multi-pass respiratory gating technique, the gated helical tomotherapy is achieved
by delivering only the beam projections that occur within a respiratory gating window,
while blocking the remaining beam projections via the complete closure of all MLC
leaves. After each pass, the couch is reset to its starting position, and the treatment
recommences at a different phase of tumor motion for the previously blocked beam
projections to coincide with the gating window. This process is repeated until the entire
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plan dose is delivered (“full gating”). However, this approach may not be clinically
feasible, as the number of passes (n) required may become too high, due to the
complexities of tumour motion patterns. Thus, an alternative approach is halting the
gating process after a certain number of passes, and delivering the entire remaining
planned dose in a subsequent final pass without gating (“partial gating”).
In Figure 4.1, the multi-pass respiratory gating method with the full gating approach is
illustrated for a simple non-IMRT case. In Figure 4.1 a), the displayed leaf opening
sinogram (right panel) is designed to treat an off-axis target (left panel). For illustrative
purposes, we assume a uniform fluence from all beam projections. The gating window is
centered at the end-expiration phase with an unusually high duty cycle (dc) of 50%,
where the entire leaf opening sinogram is completed over two gated passes (Figure 4.1 b
and c). The peak-to-peak amplitude (2A) of target motion in this example was 2.0 cm,
yielding a residual motion of 1.0 cm within the gating window.

4.2.1.3.1

Ideal Scenario: Sinusoidal Waveform

The feasibility of the full gating approach was first tested for sinusoidal motion with a
constant amplitude (A) and target motion period (Tr), through experimental measurements
using film (Section 4.2.3) and computer simulation (Section 4.2.4) for a single fraction.
The test cases included a non-IMRT helical tomotherapy case (Section 4.2.2.1) exhibiting
the dose rippling and dose rounding effects, and an IMRT helical tomotherapy case
(Section 4.2.2.2) displaying the IMRT leaf opening asynchronization and dose rounding
effects. Phase gating was used with the gating window centered at the end-expiration
phase for two different duty cycles (dc) of 50% and 25%. The duty cycle of 25%
represents the clinical scenario, while the duty cycle of 50% was chosen as the “stress”
case for the proposed gating method.

4.2.1.3.2

Realistic Scenario: RPM Waveform

Both full and partial gating methods were then investigated for a patient respiratory
motion pattern, through computer simulation (Section 4.2.4) for the IMRT helical
tomotherapy case (Section 4.2.2.2). The patient waveform was acquired by the Real-time
Position Management (RPM) system (Varian Medical Systems, Palo Alto, CA). In this
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study, it was assumed that the anterior-posterior motion of the RPM block placed on the
patient’s abdomen represented the actual tumour motion.

Amplitude gating was

employed due to the constantly changing amplitudes of the RPM trace, including two
large erratic peaks that may represent unexpected physiological events such as patient
coughing. For different fractionation schemes (1, 3 and 30 fractions), we determined the
optimal gating parameters to keep the root-mean-square of dose deviations (RMS∆D)
from the planned dose profile below 1.0%, both inside the PTV and for the entire profile.
The amplitude gating window size ranged from 4 to 7 mm, in an increment of 1 mm.
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Figure 4.1: Multi-pass respiratory gating technique with the full gating approach
(dc = 50%). (a) Left panel: Off-axis target, Right panel: Leaf opening sinogram. (b)
First gated pass. Only the beam projections occurring within the gating window are
delivered. (c) Second gated pass. The treatment commences at a different starting
phase of the tumour motion to deliver the previously blocked beam projections.
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4.2.2
4.2.2.1

Treatment Planning
Non-IMRT Helical Tomotherapy Plan

A non-IMRT plan was designed to deliver uniform fluence to the central axis of a 5.5
cm-long cylindrical target volume, aligned with the axis of gantry rotation. The target
volume was located inside the film insert that moves through an opening of the body
phantom (Modus Medical Devices Inc., London, Canada), shown in Figure 4.2 a).
Maximum leaf opening time (to = 1) was assigned to the four central leaves with the rest
of the leaves remaining fully closed (to = 0) for all beam projections over four gantry
rotations (R = 4). A fan beam thickness (b) of 2.5 cm was used with a pitch factor (p) of
0.8 and a gantry rotation period (Tg) of 16 s. A pitch factor of 0.8 was chosen instead of
typical pitch factors of less than 0.3 for lung cancer tomotherapy [31], in order to
intentionally generate dose rippling.

4.2.2.2

IMRT Helical Tomotherapy Plan

The IMRT helical tomotherapy plan was generated using the stationary CT images of the
body phantom (ρ = 1.18 g cm-3, length = 12 cm, width = 30 cm, height = 20 cm). On the
CT images of the body phantom (Figure 4.2 b), a virtual C-shaped PTV (length = 6.6 cm)
was delineated to wrap around a cylindrical OAR (length = 3.6 cm), using a commercial
treatment planning system (Pinnacle 8.0d, Philips Medical Systems). The CT images and
contours were then exported to the tomotherapy treatment planning system
(TomoTherapy version 2.2.2, TomoTherapy Inc., Madison, WI), where a dose of 2.0 Gy
was prescribed to 95% of the PTV with the maximum OAR dose being limited to 0.8 Gy.
A pitch factor (p) of 0.287 (i.e. 0.86 / 3) was selected to minimize the “thread artifact”
[32] with a fan beam thickness of 2.5 cm. The optimized dose distribution in a transverse
plane is shown in Figure 4.2 c). The leaf opening sinogram generated through the plan
optimization consisted of 819 beam projections (R ~ 16).
The plan leaf opening sinogram was then truncated to 408 beam projections (R = 8) by
eliminating the first 252 and the last 159 beam projections, decreasing the plan dose from
2.0 Gy to 1.75 Gy. This was done to shorten the length of the PTV from 6.6 cm to 3.24
cm, so that the resulting PTV region fell well within the length of the body phantom
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while in motion. This was deemed acceptable, as the objective of this study was not to
reproduce a particular plan, but to investigate how the multi-pass gating technique can
effectively minimize the dose discrepancies between the gated and planned dose
distributions.

Figure 4.2: IMRT helical tomotherapy plan for a stationary target. Dose of 2.0 Gy
was prescribed to 95% of the PTV with the maximum OAR dose being limited to 0.8
Gy. (a) Photograph of the lucite body phantom (ρ = 1.18 g cm-3, length = 12 cm,
width = 30 cm, height = 20 cm) mimicking a human torso. The different features of
the motion phantom are labelled in the “zoomed-in” picture. (b) Transverse CT
image of the stationary body phantom with the contours of the PTV (dark), OAR
(light), and the phantom outline. The coronal film insert remained stationary inside
the body phantom at its mid-position during the CT scanning process. (c) Plan dose
distribution in the transverse plane.
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4.2.2.3

Gated Leaf Opening Sinograms

A series of gated leaf opening sinograms was generated for each plan leaf opening
sinogram, to experimentally simulate a multi-pass gated delivery. The plan leaf opening
sinograms for the non-IMRT and IMRT cases were modified according to the gating
parameters, using a code written in MATLAB (Mathworks, Natick, MA).

For the

modification process, the plan leaf opening sinogram must be first transposed, as shown
in Figure 4.3 a). Only the beam projections occurring within the gating window are left
unchanged, while the remaining beam projections are replaced with a relative leaf
opening time value of ‘0’ to “block” the radiation delivery (Figure 4.3 b). When more
than half of a beam projection overlaps with the gating window, the beam projection is
deemed to be inside the gating window, and vice versa. Thus, the actual “Beam ON”
time per tumour motion cycle may be either longer or shorter than the intended duration
set by the gating window.

For each investigated case in this study, however, the

cumulative difference over the entire treatment was zero. For the subsequent passes, the
beam projections completed during the previous passes are now “blocked” to avoid
replication, while the previously undelivered beam projections are assigned with their
original leaf opening time (Figure 4.3 c). The resulting gated leaf opening sinograms
were then re-transposed and converted to the tomotherapy file format for deliveries at the
treatment console.
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Figure 4.3: Leaf opening sinograms for the full gating method. (a) “Transposed”
plan leaf opening sinogram. The row and column indices now represent projection
number and leaf number, respectively. (b) Gated leaf opening sinogram for the first
pass. Only the beam projections occurring within the gating window are left
unchanged, while the remaining beam projections are replaced with a relative leaf
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opening time value of ‘0’ to “block” the radiation delivery. (c) Gated leaf opening
sinogram for the second pass. The beam projections completed during the first pass
are “blocked”, while the previously undelivered beam projections are assigned with
their original leaf opening time.

4.2.3

Experimental Measurements for a Sinusoidally Moving
Target

The experimental measurements were carried out on the helical tomotherapy machine
(Hi-Art II, TomoTherapy Inc., Madison, WI) to investigate the effectiveness of the multipass gating technique, using a body phantom with a moving film insert (Figure 4.2 a).
The film insert travelled in a sinusoidal manner with a fixed target motion period (Tr) and
amplitude (A).

4.2.3.1

Motion Body Phantom

The motion phantom (Figure 4.2 a) consists of a lucite body phantom (ρ = 1.18 g cm-3,
length = 12 cm, width = 30 cm, height = 20 cm) mimicking a human torso, and a
sinusoidally moving lucite film insert (ρ = 1.18 g cm-3, length = 18 cm, diameter = 8 cm).
The film insert was positioned to move through the central opening of the body phantom.
The film (length = 15 cm, width = 6 cm) was placed on the coronal plane centered along
the axis of gantry rotation, inside the film insert. The film insert contains five pins at its
inside corners (2 at one corner, and 1 at each of the three corners) to generate pinprick
landmarks on each film, which were later used to align a pair of scanned film images for
direct dosimetric comparisons.

The amplitude of the film insert motion is set by

adjusting the position of the translation stage holding film insert. The motion phantom is
also equipped with a “chest-height” platform, whose vertical up-and-down motion
represents the anterior-posterior (AP) motion of a “chest wall”, and moves with an
identical frequency as the film insert. The period of the film insert motion was verified
by measuring the positions of the optical markers placed on the platform, using an optical
tracking camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz.
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4.2.3.2

Calibration for Film Dosimetry

The calibration process was performed at the helical tomotherapy, on the same day of the
experiment. A cylindrical solid water phantom (“Cheese” phantom, length = 18 cm,
diameter = 30 cm, TomoTherapy Inc., Madison, WI) was used. A 10” x 12” EDR2 film
was placed on the coronal plane bisecting the “Cheese” phantom, which was centered
along the isocentre. The calibration procedure delivered eight 3-cm2 square fields with
known dose of 30.5 cGy, 65.2 cGy, 100.9 cGy, 128.2 cGy, 159.5 cGy, 188.9 cGy, 215.0
cGy, and 244.4 cGy. The calibration film was processed along with a blank film to
enable background subtraction. The developed films were scanned with a Vidar VXR-16
DosimetryPro scanner (Vidar Systems Corporation, Herndon, VA), and analyzed with the
RIT113 V4 software (Radiation Therapy Dosimetry Software, Colorado Springs, CO). A
region of interest (ROI) of 2 cm2 was placed inside each of the eight different fields on
the calibration film and within the blank film. The average optical densities (O.D.) of the
ROIs were then used to generate an O.D. versus dose calibration curve.

4.2.3.3

Radiation Delivery

All the film experiments were carried out in the non-clinical “service” mode at the helical
tomotherapy unit. For each case, three different delivery scenarios were performed: (1)
“no motion”, (2) “motion, no gating”, and (3) “motion, gating”.

An electronic

communication was established between the tomotherapy machine and the motion
phantom, such that the film insert motion would commence once the gantry angle
reached zero. For the “no motion” and “motion, no gating” scenarios, the starting phase
of the film insert motion was set to zero, by positioning the film insert at its mid-position
before the start of radiation delivery. For the “motion, gating” scenario, the film insert
position was adjusted to commence at a different phase for each pass.
Ideally, the starting positions of the film insert for Scenario (1) & (2) should correspond
to the average film insert position inside the gating window for Scenario (3). However,
this will require a separate CT scan of the body phantom for each case, with the film
insert positioned according to the target motion amplitude (A) and gating parameters. In
this particular situation, the anatomy of the body phantom does not vary radiologically
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along the longitudinal direction. Thus, the stationary (1) and non-gated (2) dose profiles
can be aligned with the gated dose profiles (3) by simply applying a rigid shift (∆y) along
the longitudinal direction, which was equal to the average target position inside the gating
window.

4.2.3.4

Experimental Data Analysis

During the experimental data analysis, the dose deviations from the planned dose profile
were evaluated inside the PTV. This task was performed to determine the combined
effects of the different dose discrepancies, and the resulting improvements with the multipass gating technique. For the non-IMRT helical tomotherapy case, penumbral size and
dose rippling magnitude were introduced as the metrics to quantify dose rounding and
dose rippling effects, respectively. Penumbral size was defined as the average of two
distances between the 20% and 80% dose points (P20/80), and the 80% and 20% dose
points (P80/20). Dose rippling magnitude was measured as the dosimetric difference
between the highest dose peak and the lowest dose valley inside the PTV.
The dosimetric uncertainty of the film experiment for the non-IMRT helical tomotherapy
case (p = 0.8, Tg = 16 s, R = 4) was measured from the five measured “no motion” dose
profiles. Standard deviations were calculated for all dose points, once the dose profiles
were aligned by the center of the PTV regions. The mean of all standard deviations
values was then determined to yield a dosimetric uncertainty of +0.5%. For the IMRT
helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8), the dosimetric uncertainty of
+1.0% was calculated from the standard deviation of the maximum PTV dose for the
three “no motion” film dose distributions.

4.2.4

Computer Simulation

A computer program was developed to calculate simulated longitudinal dose profiles
along the axis of gantry rotation inside a body phantom.

The simulation program

described in a previous publication [7] was used to generate the longitudinal dose profiles
for a sinusoidally moving target. Additional parameters such as the number of passes (n)
and duty cycle (dc) were added to allow dose calculations for phase gating. The exposure
time at each longitudinal position was determined by iteratively calculating the total time
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spent simultaneously within the gating window, leaf opening window and the two jaws
defining fan beam thickness (b). The fluence profile for each gating case was produced
by summing up the fluence profiles calculated from the different passes, which was then
converted to a dose profile through the convolution process using a dose spread kernel.
The computer program was further modified to accept a RPM trace as a numerical input
waveform, and to perform dose calculations for amplitude gating. For amplitude gating,
partial deliveries of the beam projections were allowed, whereas the beam projections
were either delivered or blocked entirely for phase gating.

In order to study the

fractionation effect, a random tumour motion phase was introduced at the start of each
fraction. The resulting dose profiles for the individual fractions were then accumulated to
yield a dose profile for multiple fractions.

4.3 Results
4.3.1

Non-IMRT Helical Tomotherapy Case, Sinusoidal Waveform

In Figure 4.4 a) and b), the non-gated and gated longitudinal dose profiles along the axis
of gantry rotation are presented for the non-IMRT helical tomotherapy case (p = 0.8, Tg =
16 s, R = 4).

Without gating, a penumbral size of 22 mm was measured, which

corresponded to an increase of 6 mm over the penumbral size of the planned dose profile.
With full gating (dc = 25%, n = 4), the penumbral size decreased by 5 mm to 17 mm,
which was within 1 mm of the planned penumbral size. The dose rippling magnitude was
also reduced from 3 to 0.5% by gating. In Figure 4.4 a), the dose deviations inside the
PTV ranged from -10 to 2%, with the mean dose difference of -2%. The dose deviation
of -10% was observed near the PTV boundary, due to the dose rounding effect. The
maximum dose deviation of 2% was less than the dose rippling magnitude of 3%, due to
the “dose rippling-like” feature present inside the PTV of the planned dose profile. This
dosimetric feature was attributed to the oval shape of the body phantom. In Figure 4.4 b),
the dose deviations inside the PTV were reduced to within +1%, with the mean dose
difference of 0.5%. In both Figure 4.4 a) and b), the simulated dose profiles agreed with
the corresponding measured dose profiles within a standard deviation of 0.6% inside the
PTV.
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Figure 4.4: Non-IMRT helical tomotherapy case (p = 0.8, Tg = 16 s, R = 4) delivered
in the presence of sinusoidal target motion (Tr = 8 s, A = 1.5 cm) over a single
fraction. (a) Non-gated measured and simulated longitudinal dose profiles along the
axis of gantry rotation. (b) Gated measured and simulated longitudinal dose
profiles along the axis of gantry rotation (dc = 25%, n = 4).
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4.3.2

IMRT Helical Tomotherapy Case, Sinusoidal Waveform

In Figure 4.5 a), the measured coronal dose distributions are shown for the IMRT helical
tomotherapy case (p = 0.287, Tg = 15 s, R = 8) under four different radiation delivery
conditions. Significant dose discrepancies were evident in the “motion, no gating” dose
distribution (ii), due to the IMRT leaf opening asynchronization effect. In Figure 4.5 b),
the corresponding longitudinal dose profile along the axis of gantry rotation showed
significant dose deviations ranging from -29 to 5%, with the mean dose difference of 8%.
Dose rounding effect was also observed near the PTV boundaries. The measured and
simulated dose profiles agreed within a standard deviation of 2.5% inside the PTV. In
Figure 4.5 c), the renormalized non-gated dose profiles summed over 30 fractions and 3
fractions with three different sets of random starting phases of target motion are plotted.
For the 30 fraction scenario, the dose discrepancies of -29 to 5% observed for the single
fraction case (Figure 4.5 b) decreased to range from -16 to 1%. For the 3 fraction case,
however, it was illustrated that the dose variations were dependent upon the values of
random starting phases. The first set of random starting phases yielded dose deviations (31 to 9%) larger than the single fraction case, while the second set of random starting
phases produced dose differences (-18 to -1%) that were close to the 30 fraction scenario.
On the other hand, the dose discrepancies values for the third set of random starting
phases (-19 to -10%) fell between the single fraction and 30 fractions cases.
In Figure 4.5 a), significant reductions of dose discrepancies were observed in the
“motion, 50% gating” dose distribution (iii), while the planned “no motion” dose
distribution (i) was nearly restored in the “motion, 25% gating” dose distribution (iv). In
Figure 4.5 d), the dose deviations of the measured “50% gating” profile (dc = 50%, n = 2)
ranged from -5 to 2 %, with the mean dose difference of -2%. In Figure 4.5 e), the use of
a lower duty cycle (dc = 25%, n = 4) further decreased the measured dose deviations to
range from -1 to 3%, with the mean dose difference of 2%. In Figure 4.5 d) and e), the
measured and simulated dose profiles agreed with a standard deviation of 1.0% inside the
PTV.
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Figure 4.5: IMRT helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8) delivered in
the presence of sinusoidal target motion (Tr = 8 s, A = 1.5 cm) over a single fraction.
(a) Measured coronal dose distributions under four different radiation delivery
conditions: (i) “no motion”, (ii) “motion, no gating”, (iii) “motion, 50% gating”, and
(iv) “motion, 25% gating”. The dotted lines (x = 0 cm) represent the axis of gantry
rotation. (b) Non-gated measured and simulated longitudinal dose profiles along
the axis of gantry rotation. (c) Non-gated simulated longitudinal dose profiles along
the axis of gantry rotation for 30 fractions and 3 fractions with three different sets
of random starting phases of target motion. (d) Gated measured and simulated
longitudinal dose profiles along the axis of gantry rotation (dc = 50%, n = 2). (e)
Gated measured and simulated longitudinal dose profiles along the axis of gantry
rotation (dc = 25%, n = 4).

4.3.3

IMRT Helical Tomotherapy Case, RPM Waveform

In Figure 4.6, the simulated longitudinal dose profiles acquired over 3 fractions are
plotted. Without gating, the RMS values of dose deviations (RMS∆D) were 2.42% inside
the PTV and 1.61% for the entire profile. For full gating with 6 mm gating window and 4
passes, the RMS∆D values were 2.50% inside the PTV and 1.31% for the entire profile.
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Although the full gating approach improved the alignment of the resulting dose profile to
the planned dose profile, the RMS∆D inside the PTV remained high as only 97.9 % of the
plan dose was completed over 4 passes. With the 6 mm gating window, the full gating
method required a total of 6 passes to keep the RMS∆D values below 1.0%. For partial
gating, it was possible to achieve RMS∆D values of less than 1.0%, using 4 passes that
consisted of 3 gated passes and 1 ungated pass (3 + 1). The RMS∆D values were 0.67%
inside the PTV and 0.48% for the entire profile.

Figure 4.6: IMRT helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8) delivered in
the presence of non-sinusoidal target motion (RPM trace) over 3 fractions with
random starting phases of target motion. Simulated longitudinal dose profiles are
calculated for planned radiation delivery, radiation delivery without gating, full
gating with 6 mm gating window and 4 passes, and partial gating with 6 mm gating
window and 3 + 1 passes.

In Table 4.1, the optimal gating parameters are summarized for both gating approaches
for three different fractionation schemes. For a single fraction, 4 mm was the maximum
residual motion allowed to keep the RMS∆D values below 1.0%. With the small gating
window of 4 mm, large numbers of passes were needed for both full (12) and partial
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gating (7 + 1) methods. For 3 fractions, the required numbers of passes were reduced
significantly to 6 passes for full gating and 3 + 1 passes for partial gating, with a 6 mm
gating window. For 30 fractions, the numbers of passes used were 5 and 2 + 1, with the
gating windows of 7 mm and 6 mm for full and partial gating methods, respectively.
Table 4.1: Optimal gating parameters for different fractionation schemes.

4.4 Discussion
4.4.1

Treatment Planning

Treatment planning for the multi-pass gating delivery will require the acquisition of a
4D-CT data set [33-35]. The CT data set reconstructed at the phase corresponding to the
gating window must be used for target delineation and plan optimization. During the CTscanning, the anterior-posterior (AP) position of the patient’s abdomen should also be
monitored with the RPM system. The correlation between the internal tumour motion
and the motion of the RPM block must be verified, so that the tumour position can then
be monitored reliably during the treatment.
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4.4.2

Selection of Gating Parameters

The selection of the gating parameters is based on the trade-off between the accuracy and
efficiency of the gated dose delivery. Decreasing the duty cycle or the gating window
size will reduce the residual tumour motion during radiation delivery, thus potentially
improving the accuracy of dose delivery.

However, this occurs at the expense of

increasing the number of passes and the treatment time. This was the motivation behind
the proposal of the partial gating approach. The results presented in Table 4.1 shows that
the partial gating approach requires fewer passes than the full gating method for all three
fractionation schemes. Full gating always needs nearly 100% of the plan dose to be
delivered, regardless of the fraction number. For partial gating, the required percents of
plan dose delivered before the last ungated pass were much smaller than 100%, with the
delivered percent of the plan dose decreasing with the fraction number. The percents of
plan dose completed before the last pass were 95.7% for a single fraction, 92.9% for 3
fractions, and 82.1% for 30 fractions.
For a single fraction, large numbers of passes were needed for both gating methods to
keep the RMS∆D values below 1.0%. The number of required passes was greatly reduced
for 3 and 30 fractions, due to dose averaging over multiple fractions. However, the
differences in the numbers of passes used between 3 and 30 fractions for both gating
approaches were only one pass. This indicated that the multi-pass gating technique may
be applicable to hypofractionation employed in stereotactic radiotherapy [25-27],
although further studies will be required to validate its suitability.

4.4.3

Hardware and Software Requirements for Clinical
Implementation

Clinical implementation of the multi-pass gating technique will require the following
three components: (1) Real-time tumour position monitoring system, (2) Communication
interface for real-time feedback of tumour position, and (3) Gantry startup
synchronization.
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4.4.3.1

Real-Time Tumour Position Monitoring Systems

Currently, there are different types of indirect and direct tumour monitoring systems
available. The RPM system provides advantages in terms of its wide availability, ease of
use and non-invasiveness.

Like other indirect monitoring techniques, however, the

system works under the assumption that the correlation established prior to a treatment
will be maintained throughout the treatment. This may be especially dangerous for lung
sites, where establishing stable and reliable correlations were shown to be very difficult
[36]. Monitoring an additional tumour surrogate such as the lung air flow [37-39] may
work as an assurance check during the treatment.
The tumour position may be monitored directly with the use of electromagnetic
transponders implanted into the tumour volume [40,41].

With the Calypso system

(Calypso Medical Technologies, Inc., Seattle, WA), the electromagnetic transponders are
tracked electromagnetically by the localization array panel mounted onto the treatment
couch. The relatively compact size of the localization array panel also makes the use of
the Calypso system feasible for the ring gantry configuration of the tomotherapy
machine.

However, there are added risks of complications, due to the surgical

implantation procedure of the transponders.

4.4.3.2

Communication Interface for Real-Time Feedback

A communication interface must be established between the real-time tumour monitoring
system and the tomotherapy b-MLC control centre. In addition, the software interface
must be programmed to trigger emergency maneuvers such as full b-MLC closures,
under unexpected respiratory circumstances such as patient coughing, thereby accounting
for temporary tumour excursions. It should be noted that there is a total b-MLC latency
time of 45 ms, which consists of the leaf response latency time of 30 ms and the leaf
transit time of 15 ms [20]. Thus, in order to execute the intended leaf motions in a timely
manner, the tumour position must be anticipated 45 ms in advance. In the past, various
algorithms have been described in the literature to account for system latency during the
tumour tracking dose deliveries [42-47].
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4.4.3.3

Gantry Startup Synchronization

At the start of each gated pass, the start of the tomotherapy treatment must be
synchronized with a particular phase of tumour motion, so that the previously blocked
beam projections can potentially occur within the gating window. One may continue to
rotate the gantry, until the start of the first undelivered beam projection coincides with the
start of the gating window.
synchronization

is

However, significant time may elapse before the

established,

making

this

“waiting”

approach

impractical.

Alternatively, the tomotherapy gantry may be modified to allow for a variable gantry
speed to be used within its physical limits, only before the start of the radiation delivery.
The freedom to accelerate or decelerate the gantry will significantly reduce the “wait”
time required for synchronization. The “near-future” tumour position calculated by one
of the aforementioned predictive algorithms may be used to determine the required speed
changes. At the start of the treatment, the gantry must resume its planned speed, and
maintain it throughout the treatment.

4.4.3.4

Potential Issues and Risks of the Proposed Method

Successful execution of multi-pass respiratory gated helical tomotherapy strongly
depends on the accurate monitoring of tumour position.

Incorrect synchronizations

between the gated beam deliveries and tumour motion can potentially yield worse dose
discrepancies than the non-gated approach, as the gated beam deliveries will be biased
towards the wrong tumour positions.
Similar to the gating techniques implemented for linear accelerators, an accurate and
efficient gated dose delivery will depend on a consistent correlation between a tumour
surrogate and the actual tumour position, and a fairly regular and predictable breathing
pattern. For gated helical tomotherapy, an additional determining factor becomes the
accuracy of a predictive algorithm for anticipated tumour position. This will allow for
timely execution of b-MLC opening and closure according to the observed breathing
pattern, as well as effective gantry startup synchronization using gantry speed control.
For the different indirect tumour monitoring techniques mentioned in Section 4.4.3.1,
however, numerous opportunities exist for the correlation between a tumour surrogate
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and the tumour position to change over the course of treatment. The correlation changes
can occur between the different fractions, between the gated passes within a single
fraction, or during an individual gated pass. Thus, the correlation must be periodically
confirmed or updated with the observed changes in the tumour motion pattern. However,
measuring the internal tumour motion will require the patient to be removed from the
treatment couch for a 4D-CT acquisition [33-35], unless a CT scanner is placed in the
treatment room [48,49] to minimize the internal variations between the imaging
verification and treatment processes. The use of fluoroscopic tubes [50-54] to monitor
the tumour position in the treatment room becomes complicated for helical tomotherapy,
because the ring gantry configuration of the helical tomotherapy machine hinders the
access of these fluoroscopic tubes.
Direct monitoring approaches such as the use of the magnetic transponders are thus
recommended to allow for continuous monitoring of tumour position, at the risk of
potential surgical complications such as pneumothorax. Fixation rates of the magnetic
transponders to lung tissues were initially shown to be low in the canine lung [40], but
addressed with a modified transponder design with stability features [41]. For patients
who can not tolerate the surgical implantation of the magnetic transponders, indirect
tumour monitoring methods may still be employed, as long as patients can maintain
consistent respiratory patterns. This makes the patient selection process critical for the
gated helical tomotherapy treatment. The patient breathing reproducibility was also
shown to improve significantly with patient coaching [55-57].
Appropriate emergency maneuvers are essential for clinical implementation of the
proposed methods, in order to cope with unexpected situations. Physiological events
such as coughing that cause sudden and significant changes in the respiratory motion
pattern must trigger an interlock, in the form of full leaf closures to halt the radiation
from reaching the patient. Treatment will only resume, once the patient regains the
normal breathing pattern. Both the partially delivered beam projection and undelivered
beam projections during this suspended time period will be compensated during the
subsequent gated passes.

However, frequent interruptions during the treatment will
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significantly increase the treatment session time, making gated helical tomotherapy
impractical for a particular group of patients.

4.5 Conclusion
In this study, the feasibility of multi-pass respiratory gating technique was investigated
for both ideal and realistic tumour motion patterns. For sinusoidal motion, the PTV dose
deviations of -29 to 5% observed without gating were reduced to range from -1 to 3% for
a single fraction, using full gating with 4 passes. For a patient waveform, partial gating
required fewer passes than full gating for all fractionation schemes. For a single fraction,
the maximum allowed residual motion was only 4 mm, thus requiring large numbers of
passes for both full and partial gating methods. The number of required passes decreased
significantly for 3 and 30 fractions, allowing residual motion up to 7 mm. Overall, the
multi-pass respiratory gating method was shown to be an effective way to reduce the
various motion-induced dose discrepancies present in helical tomotherapy. Its clinical
implementation will require modest modifications to the current helical tomotherapy
control system.
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Chapter 5

5

Summary and Conclusions

This chapter summarizes all the major findings of this thesis work, and includes
discussion related to clinical implications, limitations, and future work.

5.1 Summary
In the introductory chapter, it was stated that tumour motion due to breathing presents a
significant limitation for radiotherapy of lung cancer, and more specifically for helical
tomotherapy. The research objectives were addressed in the three subsequent chapters,
investigating the nature of different motion-induced dose discrepancies for helical
tomotherapy, developing two new motion management methods to reduce these effects,
and testing the feasibility of the multi-pass respiratory gating technique, in terms of its
effectiveness and practicality, through computer simulations and film measurements with
a motion body phantom. In this final chapter, all the major findings from these chapters
are summarized, and discussed in terms of clinical implications, limitations, and required
future work.

5.2 Motion-Induced Dose Discrepancies and Beam
Junctioning Effects
In the presence of tumour motion, a number of different interactions can arise between
tumour motion and the three continuously moving subsystems (gantry, couch, and bMLC) of a helical tomotherapy unit. Our research focused on a detailed investigation of
the resulting dose discrepancies and development of challenging solutions to reduce these
effects.

In addition, there are inherent dosimetric effects arising from helical dose

delivery, unrelated to tumour motion. Beam divergence and the resulting partial beam
overlaps between different gantry rotations can lead to a “threading” dose pattern being
produced away from the axis of gantry rotation. Under special circumstances, beam
junctioning “beating” effect may also be generated along the axis of gantry rotation. In
Table 5.1, the three motion-induced dose discrepancies and two inherent beam
junctioning effects are summarized, in terms of their causes and related key parameters.
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5.2.1

Dose Discrepancies in the Presence of Tumour Motion

In this thesis, motion-induced dose discrepancies for helical tomotherapy were
categorized into three different types: (1) dose rounding, (2) dose rippling, and (3) IMRT
leaf opening asynchronization.
Table 5.1: Summary of different dosimetric effects in the presence and absence of
tumour motion in helical tomotherapy.
Section

Dosimetric Effect

Cause

Key Parameters

5.2.1

Dose Discrepancies in the Presence of Tumour Motion

5.2.1.1

Dose Rounding Effect

Dose blurring due to

tumour motion amplitude

tumour motion

(A), secondary effects due to
dose rippling (below)

5.2.1.2

5.2.1.3

Interplay between

gantry rotation period (Tg),

couch and tumour

pitch factor (p), tumour

motion

motion period (Tr)

IMRT Leaf Opening

Interplay between

dominant frequency of leaf

Asynchronization

IMRT leaf opening

opening sinogram (fs),

Effect

pattern and tumour

tumour motion period (Tr),

motion

tumour motion phase

Dose Rippling Effect

5.2.2

Inherent Dosimetric Effects in the Absence of Tumour Motion

5.2.2.1

Thread Effect

Off-axis helical beam

pitch factor (p)

junctioning
5.2.2.2

Beating Effect

On-axis helical beam

pitch factor (p), number of

junctioning

beam projections per gantry
rotation (n)*

*Not to be confused with number of gated passes, also represented by ‘n’ in Chapter 4.
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5.2.1.1

Dose Rounding Effect

Dose rounding is defined as the dose blurring of a delivered dose distribution relative to
the planned dose distribution, in the direction of tumour motion, and is especially
manifested at the edges of a treated volume. In Figure 2.5 (a), the resulting ‘softer’ dose
gradient led to the simultaneous under-dosing of the tumour volume near its boundary
and over-dosing of normal tissues just outside the tumour volume. In addition, the
superior-inferior (SI) component of tumour motion, which coincides with the direction of
couch motion, further widens the “build-up” and “build-down” of dose associated with
helical tomotherapy dose delivery, as illustrated in Figure 2.5 (b). In Chapter 2, the
magnitude of dose rounding effect was characterized by a penumbral width, calculated as
an average of two distances between the 20% and 80% dose points (P20/80) within the
“build-up” region and the 80% and 20% (P80/20) dose points within the “build-down”
region. Dose rounding effect was shown to be mainly dependent upon tumour motion
amplitude (A), with other parameters making smaller contributions. In Figure 2.5 (c), the
magnitude of dose rounding effect was shown to increase with tumour motion amplitude.
Small differences of 0.4 to 2.7 mm were observed between the two tumour motion
periods (Tr) at different tumour motion amplitudes, as the dose rippling effect (Section
5.2.1.2) present inside the target volume for Tr = 8 s led to the sharpening of the
penumbral region. Depending on the phase of tumour motion, the penumbral width can
also further increase in the presence of dose rippling effect. Additionally, use of a
smaller pitch factor may contribute to the widening of the penumbral region.19

5.2.1.2

Dose Rippling Effect

Dose rippling is caused by the interplay between the couch motion and periodic tumour
motion along the direction of couch movement. The superior-inferior (SI) component of
tumour motion directly interferes with the irradiation of tumour volume, as its direction
of motion coincides with the longitudinal movement of the treatment couch. In the

19

Dose rounding becomes more sensitive to tumour motion amplitude (A), as the treatment couch slows
down. Treatment couch velocity can be reduced by either decreasing the pitch factor (p) or increasing the
gantry rotation period (Tg).
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presence of SI motion, tumour volume is forced to move in and out of the passing
treatment beam, preventing the planned tumour volume slices from being fully treated in
a sequential manner, thus leading to non-uniform dose deposition within the tumour
volume. In Figure 2.6 (a) and (b), when a sinusoidally moving target volume is irradiated
with an unmodulated beam (i.e. non-IMRT helical tomotherapy plan), the dose rippling
effect was shown to be manifested as a series of equally-spaced dose peaks and valleys
inside the target volume, resembling a wave “interference” ripple. The successive peaks
or valleys are separated by the distance travelled by the treatment couch during one cycle
of tumour motion. However, uniform dose delivery to the target volume could still be
achieved for a special condition between the linear couch motion and periodic tumour
motion. Under this “dose equilibrium” condition, the excess or deficient dose delivered
to a particular tumour point, caused by the movement of the leading beam edge in the
tumour coordinate system, is compensated exactly by the movement of the trailing beam
edge, as illustrated in Figure 2.3 (a). In the remainder of this section, a dose equilibrium
condition for dose rippling effect will be referred to as a synchronous interplay condition.
In Chapter 2, the dose rippling parameter (β) (defined in Equation 2.6) was introduced as
a key metric to predict the presence (β ≠ integer) or absence (β = integer) of dose
rippling effect.

The β-parameter represents the number of tumour motion cycles

completed while advancing the treatment couch by one fan beam thickness.

The

relationship between an integer β value and a synchronous interplay condition was
mathematically derived in the Appendix of Chapter 2. In Figure 2.6 (c), a common β
value from different combinations of treatment and tumour motion parameters was
shown to yield comparable dose modulations, further affirming β as an appropriate
metric for dose rippling effect.
The magnitude of dose rippling was defined as the difference between the maximum dose
peak and the minimum dose valley observed inside the target region, along the axis of
gantry rotation. The dose rippling effect was then investigated as functions of tumour
motion amplitude (A) and dose rippling parameter (β). In Figure 2.6 (d), the relationship
between the magnitude of dose rippling and tumour motion amplitude exhibited a
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complex periodic pattern, with the maximum value decreasing with the tumour motion
amplitude, perhaps contrary to intuition. The observed periodicity was attributed to the
use of pure sinusoidal target motion. In Figure 2.6 (e), the magnitude of dose modulation
was plotted against β for different tumour motion amplitudes. The magnitude of dose
rippling was shown to decline rapidly with increasing β to less than 1% at β = 4.5 for all
tumour motion amplitudes. At each non-integer β value, the relationship between the
magnitude of dose rippling and tumour motion amplitude was shown to be different,
while dose rippling was absent at integer β values, as expected. In Figure 2.7 (a), it was
shown that dose rippling effect could also be observed for an IMRT helical tomotherapy
plan. The phase of tumour motion was shown to affect the positions of the dose peaks
and valleys, as well as the penumbral width, although the magnitude of dose modulation
remained unchanged.

5.2.1.3

IMRT Leaf Opening Asynchronization Effect

The IMRT leaf opening asynchronization effect arises from the interplay between the bMLC motion and periodic tumour motion. When the dominant frequency of superiorinferior (SI) tumour motion approaches the dominant frequency (fs) of the plan leaf
opening sinogram along the direction of couch movement, dose discrepancies unique to
an IMRT helical tomotherapy plan can be generated, as illustrated in Figure 2.7 (b). In
Figure 2.7 (c), the longitudinal dose profile acquired along the axis of gantry rotation
exhibited dose deviations ranging from -29% to 7% inside the PTV, yielding a rootmean-square of dose deviations (RMS∆D) equal to 14%. In Figure 2.7 (d), the IMRT leaf
opening asynchronization effect was shown to worsen with tumour motion amplitude,
while its sensitivity to the phase of tumour motion was also demonstrated in Figure 2.7
(e). The IMRT leaf opening asynchronization effect was shown to decrease significantly,
however, in the presence of more complex tumour motion. When a tumour surrogate
waveform acquired with the Real-time Position Management (RPM) system (Varian
Medical Systems, Palo Alto, CA) for a real patient was employed to represent tumour
motion, dose deviations ranging from -9% to -2% were observed inside the PTV, yielding
a RMS∆D value of 6%. The great reduction in dose deviations may be attributed to the
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absence of dominant tumour motion frequency close to the fs value, as well as the
presence of multiple frequency components making up the RPM waveform.
The presence of the IMRT leaf opening asynchronization effect could be anticipated prior
to a helical tomotherapy treatment by performing a Fourier analysis of the plan leaf
opening sinogram, as well as the tumour motion pattern to determine their respective
dominant frequencies.

In Figure 5.1, a frequency spectrum was generated for the

intensity modulation pattern of a central binary leaf from the plan leaf opening
sinogram20 generated in Chapter 2 and 4. The observed dominant frequency (fs) of 0.133
Hz closely matched the tumour motion frequency of 0.125 Hz (Tr = 8 s) employed in
Figure 2.7 (c), thus explaining the significant dose discrepancies observed in this figure.
The IMRT leaf opening asynchronization effect was not generated however, when
tumour motion frequencies close to the other frequency components of the plan leaf
opening sinogram were selected, as illustrated in Figure 5.2. Only dose rounding was
present for these tumour motion frequencies. Thus, Fourier analysis may serve as a quick
quality assurance (QA) check to ensure that no major resonance exists between the IMRT
leaf opening pattern and tumour motion. The Fourier analysis may even be performed
for a newly acquired patient waveform before each treatment fraction to account for the
inter-fraction variability of tumour motion pattern [1,2] – possibly caused by changes in
tumour volume and shape, as well as patient’s respiratory capacity over the course of
radiotherapy treatment.

20

This plan leaf opening sinogram refers to the truncated version of the plan leaf opening sinogram
generated in Figure 2.1 and 4.2. Truncation process is explained in both Section 2.2.1.4 and 4.2.2.2.
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Figure 5.1: Frequency spectrum for the intensity modulation pattern of a central
binary leaf. Its dominant frequency (fs) was observed at 0.133 Hz.

Figure 5.2: Simulated longitudinal dose profiles along the axis of gantry rotation for
the IMRT helical tomotherapy plan (p = 0.287, Tg = 15 s, R = 8) generated for
different tumour motion periods (Tr) with a tumour motion amplitude (A) of 1.5 cm.
The IMRT leaf opening asynchronization effect was observed only for Tr = 8 s.
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5.2.2

Dosimetric Effects in the Absence of Tumour Motion

The two inherent beam junctioning effects for helical tomotherapy, unrelated to tumour
motion are the (1) thread effect, and (2) beating effect. These effects are not classified as
dose discrepancies (i.e. dose differences between the planned and delivered dose
distributions), because they are clinically accounted for during the dose calculations of
the treatment planning system. In this work, they have been observed experimentally, as
other investigators have [3], and hence are only discussed here briefly.

5.2.2.1

Thread Effect

The thread effect is a well known off-axis helical beam junctioning effect, inherent to
helical tomotherapy [3]. Even with perfect beam overlaps along the axis of gantry
rotation for a uniform dose delivery, the thread effect can still be generated away from
the axis of gantry rotation, due to beam divergence. As the projected fan beam thickness
changes according to the distance from the x-ray source, alternating beam overlap and
gaps are created off-axes. The resulting dose peaks and valleys both follow a helical
trajectory, resembling a screw thread. Fluence also changes according to an inversesquare of distance from an x-ray source; attenuation and scatter are other contributing
factors for the thread effect [3]. The successive dose peaks and valleys along off-axes are
separated by a distance equal to the couch translation during each gantry rotation (i.e.
pitch factor (p) * fan beam thickness (b)), as illustrated in Figure 3.4. Dose difference
between dose peaks and valleys was shown to increase with off-axis position, as expected
with greater divergence distance, according to the results from Table 3.3.

5.2.2.2

Beating Effect

The beating effect is an on-axis beam junctioning effect generated only under highly
specific treatment conditions. In Chapter 3, n / p ratio was used as a metric for predicting
the presence (n / p = non-integer) and absence (n / p = integer) of the beating effect, as
indicated by the results summarized in Table 3.3, where n is the number of beam
projections per gantry rotation and p is the pitch factor. The n / p ratio represents the
number of beam projections delivered (Nb), after the treatment couch moves a distance
equal to one fan beam thickness:
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Nb =

n
n
×b =
p ⋅b
p

(5.1)

With a non-integer n / p ratio, the total number of beam projections encountered by
different parts of a target volume alternates between two values, leading to the periodic
dose peaks and valleys along the direction of couch motion, observed in Figure 3.11.
The magnitude of beating effect was shown to decrease with an increasing n / p ratio, as
the relative dosimetric contribution of the extra beam projection decreases with an
increasing number of beam projections. The decreasing separation distance between dose
peaks with increasing n / p ratio, further contributes to the dose peak reduction. The
separation distance between the successive dose peaks or valleys is equal to the couch
increment per beam projection (i.e. projection increment defined in Equation 3.3).
The work in Chapter 3 was done before the arrival of the Hi-Art II helical tomotherapy
machine (TomoTherapy Inc., Madison, WI) at the London Regional Cancer Program
(LRCP) in May of 2004.

Helical tomotherapy dose delivery was experimentally

simulated using a linear accelerator x-ray beam by delivering a series of static beams
from different gantry angles and couch positions. The results in Chapter 3 could be
replicated with the current helical tomotherapy unit by assigning a very short leaf
opening time per beam projection, mimicking a static beam projection, and a pitch factor
larger than 7 to keep the n / p value below 7.5. However, the magnitude of dose peaks
may still be reduced slightly, due to the presence of continuous couch motion.

5.3 Clinical Implications
In this section, the clinical implications for each of the motion-induced dose
discrepancies produced in the presence of tumour motion, and the two beam junctioning
effects inherent to helical tomotherapy dose delivery will be discussed.

5.3.1

Presence of Tumour Motion

Dose rounding is a clinically-relevant effect that worsens with tumour motion amplitude,
as shown in Figure 2.5 (c). The reduced tumour dose delivered near the tumour boundary
can be compensated by increasing the treatment margin according to the magnitude of
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dose rounding. For large amplitudes of tumour motion, however, the resulting margin
expansion would significantly increase the total irradiated volume of surrounding normal
tissues, potentially increasing radiation toxicity and necessitating the use of a motion
management technique. It is highly unlikely that the dose rippling effect would yield
significant impact in clinical practice, where pitch factors of less than 0.3 are typically
used with gantry rotation periods of 15-20 seconds. Use of such treatment parameters
would likely yield β values much greater than 4.5, where the magnitude of dose rippling
was shown to become negligible in Figure 2.6 (e) – unless unusually long tumour motion
periods are exhibited by the patients. The IMRT leaf opening asynchronization effect
could introduce significant dose discrepancies within the tumour volume, as illustrated in
Figure 2.7 (b) and (c). For a conventional fractionation scheme, however, the dose
deviations resulting from the IMRT leaf opening asynchronization effect may “wash out”
over multiple fractions. In Figure 2.7 (e) and Figure 5.3, the simulated dose profiles
accumulated over 30 fractions exhibited only dose rounding in the presence of sinusoidal
and non-sinusoidal target motion, respectively. A randomly selected tumour motion
phase was assigned at the start of each fraction for calculation of these cumulative dose
profiles. On the other hand, the IMRT leaf opening asynchronization may still have a
clinical impact, when hypofractionation schemes are employed.

In Figure 4.6, the

simulated dose profile accumulated over 3 fractions without gating for non-sinusoidal
target motion, exhibited both IMRT leaf opening and dose rounding effects, yielding an
RMS∆D of 2.4% within the PTV.

Thus, for clinical practice, the use of a motion

management technique may become necessary during helical tomotherapy treatments,
especially for patients displaying large amplitudes of tumour motion being treated with
hypofractionation schemes.
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Figure 5.3: Simulated longitudinal dose profiles along the axis of gantry rotation for
the IMRT helical tomotherapy plan (p = 0.287, Tg = 15 s, R = 8) accumulated over 30
fractions in the presence of a non-sinusoidal target motion (RPM trace). A
randomly selected tumour motion phase was assigned at the start of each fraction.

5.3.2

Absence of Tumour Motion

It is highly unlikely that the beating effect will be clinically relevant for helical
tomotherapy. With the number of beam projections per gantry rotation fixed at 51 and
pitch factors of less than 0.3 typically used clinically, the n / p ratio would become
extremely high and well above the value of 7.5, where a maximum dose modulation of
approximately 5% was observed, according to the results in Table 3.3. The thread effect
is accounted for during the treatment planning process. The current clinical practice at
LRCP follows the finding by Kissick et al [3], which has shown that thread effect can be
minimized by using a pitch factor that satisfies the following condition:
1
p = 0.86  , a ∈ I
a

(5.2)
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5.4 Tumour Motion Management Techniques
In this section, the feasibility of employing respiratory gating and breath-holding for
helical tomotherapy will be discussed, in terms of their effectiveness to reduce the
magnitude of each individual motion-induced dose discrepancy.

5.4.1

Multi-Pass Respiratory Gating Technique

In Chapter 2, dose rounding and the IMRT leaf opening asynchronization effect were
both shown to worsen with tumour motion amplitude (A). In addition, target motion
period (Tr) was shown to be the determining parameter for yielding interplay conditions
that can generate dose rippling or the IMRT leaf opening asynchronization effect. When
multi-pass respiratory gating is employed, the magnitude of tumour travel during beam
delivery becomes restricted to the residual motion within the gating window.
Additionally, delivering the treatment beam only during a pre-determined portion of the
tumour motion cycle introduces an effective “beam ON” tumour motion period that is
different from the actual tumour motion period (Tr). In Figure 5.4, it is illustrated that the
effective tumour motion period (Tr eff) “seen” by the treatment beam during a multi-pass
gated treatment is calculated as the product of duty cycle (dc) and tumour motion period
(Tr). Duty cycle (dc) is defined as the fraction of tumour motion cycle during which the
radiation delivery is made. Thus, the multi-pass respiratory gating technique has the
potential to address all three types of dose discrepancies by effectively reducing the
magnitude and period of tumour motion during radiation delivery. The emergence of the
Tr eff parameter also means the original definition of the dose rippling parameter (β) in
Equation 2.6 needs to be modified to accommodate for both gated and non-gated
situations, yielding a newly defined dose rippling parameter, namely the effective dose
rippling parameter (βeff):


1
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T

T

g
g
 g  =
 β =
=
β eff = 
(
)
0.01 dc  p ⋅ Tr  0.01 p dc ⋅ Tr
0.01 p ⋅ Tr eff
 0.01 dc 

(5.3)

In Figure 4.4 (b), the multi-pass respiratory gating technique was shown to effectively
reduce both dose rippling and dose rounding observed in Figure 4.4 (a). In Figure 4.4 (a),
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the two effects combined to yield an RMS∆D of 4% inside the PTV, with a dose rippling
magnitude of 3%. In Figure 4.5 (b), the RMS∆D inside the PTV was reduced to 0.7%,
while decreasing the dose rippling magnitude to 0.5%. The significant reduction in dose
rippling magnitude was attributed to establishing a synchronous interplay condition by
using a duty cycle of 25%, which changed the βeff value from 2.5 to 10. In Figure 4.5 (b),
the presence of the IMRT leaf opening asynchronization effect and dose rounding
produced dose deviations ranging from -29% to 5% inside the PTV, with an RMS∆D of
14%. In Figure 4.5 (d), 2 gated passes were employed with a duty cycle of 50% to
significantly reduce the RMS∆D to 2.4%, with the dose deviations varying from -5% to
2%. In Figure 4.5 (e), employing 4 gated passes with a duty cycle of 25% further
decreased the RMS∆D to 2%, with the dose deviations ranging from -1.5% to 3.5%.
The practicality of the multi-pass respiratory gating technique was then investigated for
more complex non-sinusoidal target motion, represented by a patient RPM waveform
(Table 4.1). For a conventional fractionation scheme consisting of 30 fractions, the
number of required passes was shown to range from 3 to 5 to keep the RMS∆D inside the
PTV below 1%. For 3 fractions, the number of required passes was shown to increase by
only a single pass over the 30-fraction scheme. Thus, the treatment session time required
for a multi-pass respiratory gated helical tomotherapy treatment may remain comparable
between different fractionation schemes. Currently, at London Regional Cancer Program
(LRCP), each helical tomotherapy treatment is assigned with a treatment session time of
30 minutes. The first half of the treatment session is dedicated to patient set-up, MVCT
acquisition for patient position verification, and patient repositioning, while the second
half consists of 5-10 minutes of “beam-ON” time and the time needed for the patient to
leave the treatment room. The use of 4 to 5 gated passes would yield a “beam-ON” time
of 20-50 minutes, and with the couch reset time totaling up to 5 minutes, the treatment
session time may last up to 75 minutes – representing an increase by a factor of 2.5.
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Figure 5.4: Position vs. time curves of the leading and trailing beam edges in the
tumour coordinate system for a multi-pass respiratory gated helical tomotherapy
treatment (p = 0.8, Tg = 16 s, R = 8), employing phase gating (dc = 50%, n = 2). The
gating window is centered around the end-expiration phase. The effective tumour
motion period (Tr eff) “seen” by the treatment beam is calculated as the product of
duty cycle (dc) and tumour motion period (Tr).
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5.4.2

Loose Helical Tomotherapy with Breath-Holding

With the breath-holding strategy, the dose rounding effect is expected to be minimized to
a negligible level, as the magnitude of tumour motion approaches zero during breathholding. The residual motion during breath-holds will vary between patients, according
to their abilities to tolerate and perform breath-holding in a reproducible manner. In
addition, minimal tumour motion during radiation delivery would likely yield negligible
interplay effects, leading to the absence of dose rippling and IMRT leaf opening
asynchronization effect.

5.4.3

Thread Effect

Although the impact of different motion-induced dose discrepancies could be minimized
by employing a motion management technique, dosimetric effects previously present in
the absence of tumour motion may resurface. In Figure 5.5, thread effect observed in the
planned “no motion” distribution (i) becomes blurred by the presence of tumour motion
in the “motion” dose distribution (ii). Interestingly, the thread effect starts to reappear in
the “gated” dose distribution acquired with a duty cycle of 50% (iii). The threading
pattern then becomes clearly visible in the “gated” dose distribution obtained with a duty
cycle of 25% (iv), as the magnitude of target motion during radiation delivery is further
reduced. The dose distributions in Figure 5.5 were generated using four fully-open
central b-MLC leaves (i.e. non-IMRT helical tomotherapy plan) with the helical
tomotherapy treatment parameters of p = 0.8, Tg = 16 s, and tumour motion parameters of
Tr = 8 s, A = 1.0 cm, yielding β = 2.5.
For loose helical tomotherapy with breath-holding, the thread effect is expected to be
absent due to the use of multiple “interlaced” helices. Interlaced helices are generated by
assigning different gantry start angles (i.e. phases) to the individual helices. As the
different helices are out-of-phase from one another, the off-axes dose modulations
produced by the individual helices are averaged out. In Figure 3.4 (b) and (d), employing
four “interlaced” helices 900 out-of-phase from one another was shown to eliminate the
thread effect observed in the original dose distributions in Figure 3.4 (a) and (c), acquired
by using a conventional tight helix. The work by Kissick et al [3] has also demonstrated
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significant reduction of the thread effect by using double helices that were 1800 out-ofphase from each other.

Figure 5.5: Central coronal dose distributions produced by a non-IMRT helical
tomotherapy plan (p = 0.8, Tg = 16 s, R = 4): (i) “no motion” dose distribution, (ii)
“motion” dose distribution (Tr = 8 s, A = 1.0 cm), (iii) “gated” dose distribution (dc =
50%, 2 passes), (iv) “gated” dose distribution (dc = 25%, 4 passes). The tread effect
previously observed in the “no motion” dose distribution (i) resurfaces in the
“gated” dose distributions ((iii) and (iv)).

5.5

Limitations and Future Work

In this section, limitations of the two proposed motion management techniques, namely
loose helical tomotherapy with breath-holding and multi-pass respiratory gating
techniques will be discussed, including recommendations to the manufacturer of the
helical tomotherapy unit. In addition, limitations of the work done in this thesis will be
described, as well as the required future work to address these limitations.
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5.5.1

Limitations of Proposed Methods

Both loose helical tomotherapy with breath-holding and multi-pass respiratory gating
techniques require much longer treatment session time because of the use of multiple
passes. In addition, patient position uncertainty could also be introduced, as the treatment
couch is retracted back to its starting position between passes and patient discomfort may
ensue.

Fortunately, the helical tomotherapy machine provides the on-board MVCT

imaging capability to verify patient position and minimize corresponding positional
uncertainty between passes, at the expense of further increasing the treatment session
time and dose received by patients.
There are other patient-related factors. Patient compliance for breath-holding remains a
significant issue for loose helical tomotherapy. Although breath-holding at either normal
inspiration or expiration could yield higher patient compliance than the 40% rate reported
for deep-inspiration breath-holding by Memorial Sloan-Kettering Cancer Center
(MSKCC) [4], nevertheless the proposed breath-holding technique for helical
tomotherapy is not applicable for all patients. The use of active breathing control device
may improve the patient compliance rate [5-7].

Effectiveness of the multi-pass

respiratory gating technique also requires the patient to maintain a fairly regular tumour
motion, in terms of tumour motion period, amplitude, and baseline position. This way,
the undelivered beam projections from each gated pass can coincide with the gating
window more easily. With extremely irregular tumour motion patterns, completing all
planned beam projections under a reasonable number of gated passes will become very
difficult, making the patient selection process crucial. For practical purposes, the partial
gating approach described in Chapter 4 should be strongly considered over the full gating
method. For partial gating, once a certain percentage of beam projections are delivered,
all remaining beam projections are delivered without gating, thus keeping the total
number of passes used under a reasonable limit. In Table 4.1, it was shown that partial
gating required 8 passes to achieve an RMS∆D of less than 1% for a single fraction,
compared to 12 passes for full gating. For 3 and 30 fractions, the partial gating approach
needed 2 less passes than full gating, requiring 4 and 3 passes, respectively.
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5.5.2

Recommendations to the Manufacturer

For clinical implementation of loose helical tomotherapy, modifications to the current
treatment planning platform must be made by the manufacturer to provide the treatment
planning capability for multiple helices with large pitch factors. However, concerns
remain as conformality of dose distribution to tumour volume may be greatly
compromised from the use of extremely large pitch factors. Thus, an extensive treatment
planning exercise must be performed with large pitch factors to determine its clinical
feasibility, in terms of dose delivery accuracy and number of loose helices required to
satisfy different clinical criteria.
Clinical implementation of respiratory gating for helical tomotherapy would require an
electronic communication to be established between the tumour monitoring system and
the b-MLC control center. An automatic emergency maneuver in the form of full b-MLC
closure would also be required, in the event that the tumour motion pattern undergoes an
unexpected change, triggered by a physiological event such as coughing.

As most

patients would exhibit some degree of irregularity in their tumour motion patterns, it is
recommended for the manufacturer to provide variable speed capability for both the
gantry and the treatment couch. Having these additional degrees of freedom would make
it easier for the undelivered beam projections to be placed within the gating window
during subsequent passes.

5.5.3

Limitations of Current Work and Future Work

A major limitation of the computer simulation model used in this thesis was that the
calculation of each dose profile was restricted to the axis of gantry rotation. A capability
to generate dose profiles along off-axes would enable one to investigate the 3D impact of
tumour motion on helical tomotherapy dose delivery. Different factors such as beam
divergence and fluence change according to an inverse-square of distance from the x-ray
source should be accounted for during the calculations of off-axes dose profiles. For
experimental measurements, a gel dosimeter [8-10] may be used instead of film to
acquire 3D dose distributions.
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The dosimetric impact of more complex non-sinusoidal tumour motion should be
investigated experimentally. The motion body phantom used in this thesis was only
capable of producing sinusoidal motion in one direction, with adjustable tumour motion
amplitude (A) and period (Tr). The most recent version of the Modus respiratory motion
phantom is equipped with a programmable motor capable of replicating different patientrelated motion waveforms (Modus Medical Devices Inc., London, ON), such as the RPM
waveform used for computer simulation results in Table 4.1. The dosimetric impact of
tumour motion components along different directions should also be investigated
individually or in combination. Motion along the anterior-posterior (AP) direction would
affect the fluence reaching the target volume, while motion along the lateral the left-right
(LR) direction would directly interfere with the b-MLC motion, as it runs perpendicular
to the movement of each leaf. In a simplified setup, 1D target motion could be made to
yield 3D motion components by rotating and tilting the entire motion body phantom
assembly used in Chapter 2 and 4. A commercially available dynamic thorax phantom
(CIRS, Norfolk, VA) provides 3D target motion by simultaneously applying translational
and rotational motions to a cylindrical insert made of lung equivalent material, containing
a spherical target volume.
Lung deformation has been modelled by utilizing deformable lung-equivalent material
surrounding a target volume, such as sponge [11,12], as well as employing a balloon
connected to a piston to mimic a human diaphragm [12]. Finally, a non-spherical target
volume with a more realistic tumour shape has been produced using flexible resin [13].
The effect of lung deformation on the resulting dose distributions can also be investigated,
using a deformable gel dosimeter currently being developed at the London Regional
Cancer Program (LRCP). A deformable gel dosimeter is created by producing gel inside
a latex balloon. Dose calculations on 4D-CT datasets at different phases can also be
performed to investigate the effect of lung deformation on the resulting dose distributions,
one phase at a time. Robust optimization approach [14] may be used to account for
anticipated motion-induced dose discrepancies in advance during the plan optimization
process, in addition to other types of uncertainties. The current approach by Heath et al,
however, does not account for the interplay between the MLC motion and tumour motion,
while providing dose rounding reduction, thus requiring further improvements.
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5.6 Conclusions
In this thesis, we have isolated three distinctively different types of motion-induced dose
discrepancies for helical tomotherapy, namely dose rounding, dose rippling, and the
IMRT leaf opening asynchronization effect. Each effect was shown to exhibit unique
characteristics, in relations to the different tumour motion and helical tomotherapy
treatment parameters. The major dose discrepancies to be considered in clinical practice
are dose rounding and the IMRT leaf opening asynchronization effect.

For a

conventional fractionation scheme, the dose rounding effect remains the major concern,
which can be compensated by assigning a larger treatment margin around the tumour
volume. For hypofractionation schemes, the IMRT leaf opening asynchronization effect
can become an additional concern by introducing dose discrepancies within the tumour
volume, necessitating the use of a motion management technique.
Two new motion management methods have thus been developed for helical
tomotherapy, in the form of loose helical tomotherapy with breath-holding and multi-pass
respiratory gating. The feasibility of the multi-pass respiratory gating technique was
demonstrated in terms of its effectiveness and practicality, through computer simulations
and film measurements performed in a motion body phantom. For sinusoidal target
motion, the proposed method was shown to reduce the RMS∆D inside the PTV from 14%
to 2.7% and 2% for respective duty cycles of 50% and 25% requiring 2 and 4 gated
passes. For more realistic non-sinusoidal tumour motion causing an RMS∆D of within the
PTV, the required numbers of passes to keep the RMS∆D below 1% were shown to range
from 3-5 passes for 30 fractions, and 4-6 passes for 3 fractions, demonstrating the
feasibility of the multi-pass respiratory gating approach. In conclusion, employing multipass respiratory gating during helical tomotherapy was shown to greatly reduce the
different types of dose discrepancies, and decrease the required margin size, potentially
reducing radiation toxicity and allowing dose escalation for better tumour control.
Clinical implementation of the multi-pass respiratory gating technique would require a
number of electronic control and communication modifications to the existing helical
tomotherapy machine, which would lead to significant improvements in the dose
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distributions delivered for lung tomotherapy treatments – especially for patients
exhibiting large tumour motion who are treated with hypofractionation schemes.
Unique breathing patterns exhibited by each patient warrant a patient-specific approach
during the treatment planning and dose delivery processes of a helical tomotherapy
treatment.

The fundamental understanding of the different motion-induced dose

discrepancies acquired in this thesis work will greatly help with the patient selection
process to extract maximum clinical benefit with or without the use of a motion
management technique. The knowledge gained in this work on different interplay effects
can also be applied to other treatment modalities, including traditional cone beam
radiotherapy techniques, as well as more specialized techniques such as stereotactic body
radiotherapy employing hypofractionation. Thus, it is hoped that the results of this thesis
will help improve the clinical outcomes for radiotherapy of lung cancer – a disease that
continues to remain a challenge for conventional treatment techniques.
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Appendices
Appendix A: Supplementary Material for Chapter 2
Mathematical condition (β = integer) for a synchronous interplay between the couch
motion and the longitudinal target motion for a non-IMRT helical tomotherapy
delivery

In the tumour coordinate system (Figure 2.2 b), the longitudinal boundaries of the fan
beam H (y) can be defined by the two Heaviside step functions, HT (y) and HL (y) along
the axis of gantry rotation. HT (y) and HL (y) represent the trailing and leading beam
edges respectively, whose positions are determined by the functions, yT (t) and yL (t). In
the tumour coordinate system, the fan beam position changes with respect to the
stationary target volume:

H (y) = HT (y) − H L (y)
1

H T ( y ) = H ( y − yT (t )) = 1 2
0

1

H L ( y ) = H ( y − y L (t )) = 1 2
0


(1)
for y > yT (t )

for y = yT (t )

for y < yT (t )
for y > y L (t )

(2)

for y = y L (t )

for y < y L (t )

where HT (y) and HL (y) represent the trailing and leading beam edges, respectively,
and yT (t) and yL (t) are the positions of the trailing and leading beam edges as
functions of time in the tumour coordinate system, defined as following:

yT (t ) =

p ⋅b
D b p ⋅b
p ⋅b⋅ R b
2π
2π
−
t + A sin
t− − =
t + A sin
t−
Tg
Tr
Tg
Tr
2 2
2
2

p ⋅b
D b p ⋅b
p ⋅b ⋅ R b
2π
2π
+
y L (t ) =
t + A sin
t− + =
t + A sin
t−
Tg
Tr
Tg
Tr
2 2
2
2

(3)
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where p is the pitch factor, b is the fan beam thickness, Tg is the gantry rotation
period, D is the total couch travel during the treatment, R is the number of gantry
rotations competed during the treatment, Tr is the period of tumour motion, and A is
the one-half of the peak-to-peak amplitude (2A) of tumour motion along the
longitudinal direction (+y).
Each longitudinal point y is irradiated at a given time t, while the point is located between
the fan beam edges. The radiation exposure time (∆t) is calculated for each point by
integrating the fan beam function H (y) over the treatment time (0 < t < R * Tg):

∆t ( y ) = ∫

R⋅Tg

t =o

=∫

R⋅Tg

t =o

H ( y ) dt = ∫

R⋅Tg

t =o

(H T ( y ) − H L ( y )) dt

(H ( y − yT (t )) − H ( y − y L (t ))) dt

(4)

The fluence (Φ) received by each point is then determined by multiplying the radiation
exposure time (∆t) by the fluence rate (φ). The fluence rate is assumed to be constant in
this study:

Φ( y ) = φ ⋅ ∆t ( y ), φ = constant

(5)

In the absence of tumour motion, Tg / p is the time required for the couch to travel a
distance equal to one fan beam thickness (b). This means the trailing beam edge position
reaches its corresponding leading beam edge position after the elapsed time of Tg / p:
y L (t i ) = yT (t i + Tg p )

(6)

In the presence of tumour motion, the above Condition (6) is reproduced under a
synchronous interplay condition (β = integer) as Condition (7), shown as the following:
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y L (t ) =

p ⋅b
D b
2π
t i + A sin
ti − +
Tg
Tr
2 2

Tg  p ⋅ b 
T 

2π
 t i + g  + A sin
yT  t i +  =
p  Tg 
p
Tr


T  D b

 t i + g  − −
p 2 2

2πTg  D b
 2π
p ⋅b
− −
t i + b + A sin 
ti +
=
p ⋅ Tr  2 2
Tg
 Tr
=

 2π
 D b
p ⋅b
t i + A sin 
t i + 2πβ  − +
Tg
 Tr
 2 2

=

 2π
 D b
p ⋅b
t i + A sin 
t i + β (2π ) − +
Tg
 Tr
 2 2

 2π

2π
Since β = integer , A sin 
t i + β (2π ) = A sin
ti
Tr
 Tr

Tg  p ⋅ b

2π
D b
∴ yT  t i +  =
t i + A sin
t i − + = y L (t i )
2 2
p  Tg
Tr


(7)

Going back to Equation (5) and substituting Equation (4) into (5),
Φ( y ) = φ ⋅ ∆t ( y )
=φ

R⋅Tg

∫ (H ( y − y (t )) − H ( y − y (t ))) dt
t =o

T

L

R⋅Tg
R⋅Tg
= φ  ∫ H ( y − yT (t )) dt − ∫ H ( y − y L (t )) dt 
t =0

 t =0

Substituting Condition (7),

 R⋅Tg

R⋅Tg
 Tg   
Φ( y ) = φ  ∫ H ( y − yT (t )) dt − ∫ H  y − yT  t +   dt 

t =0
 t =0
p   



(R⋅Tg +Tg p )
R⋅Tg
H ( y − yT (t )) dt 
= φ  ∫ H ( y − yT (t )) dt − ∫
t
t
T
p
0
=
=
g


(R⋅Tg +Tg p )
R ⋅Tg
 R⋅Tg

H ( y − yT (t )) dt + ∫
H ( y − yT (t )) dt  
= φ  ∫ H ( y − yT (t )) dt −  ∫
t = R⋅Tg
 t =Tg p

 t =0
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Since 0 ≤ t ≤ R ⋅ Tg ,

∫

(R⋅Tg +Tg p )

t = R ⋅Tg

H ( y − yT (t )) dt = 0,

R⋅Tg
R⋅Tg
H ( y − yT (t )) dt  = φ
Φ( y ) = φ  ∫ H ( y − yT (t )) dt − ∫
t
t
T
p
=
=
0
g



∫

Tg p

t =0

H ( y − yT (t )) dt

(8)

Tg

and β = integer,
p
p ⋅b
(0) + A sin 2π (0) − D − b = − D − b
yT (0 ) =
2 2
2 2
Tg
Tr

For 0 ≤ t ≤

 Tg
yT 
 p

 p ⋅ b  Tg
 =

 Tg  p


2π
 + A sin
Tr


 Tg

 p

 D b
D b
D b
 − − = b + A sin 2πβ − − = − +
2 2
2 2
 2 2
Tg
D b
D b
∴ − − ≤ yT (t ) ≤ − +
for 0 ≤ t ≤
2 2
2 2
p
Since the target region is positioned between −
∴ y ≥ yT (t ) for 0 ≤ t ≤

D b
D b
+ ≤y≤ − ,
2 2
2 2

Tg
p

∴ H ( y − yT (t )) = 1 for 0 ≤ t ≤

Tg
p

Back to Equation (8),
Φ( y ) = φ

Tg p

∫

t =0

 Tg
H ( y − yT (t )) dt = φ ⋅ 
 p





Therefore, under a synchronous interplay condition (β = integer), the fluence inside the
target region remains constant, thus leading to the absence of dose rippling.
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